var title_f10_2_10272="VKC shield ulcer";
var content_f10_2_10272=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F64926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F64926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Corneal ulceration in vernal keratoconjunctivitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Corneal epithelial ulceration in vernal keratoconjunctivitis (VKC) is sometimes referred to as a \"shield ulcer\" because of the appearance of the epithelial breakdown. These ulcers can be quite resistant to therapy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10272=[""].join("\n");
var outline_f10_2_10272=null;
var title_f10_2_10273="Porcelain gallbladder US";
var content_f10_2_10273=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F80835&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F80835&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Porcelain gallbladder",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 332px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasound of the abdomen reveals a thickened gallbladder wall with dense calcification and a marked acoustic shadow that could be confused with a large gallstone.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Salam F Zakko, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10273=[""].join("\n");
var outline_f10_2_10273=null;
var title_f10_2_10274="Tinea pedis bullous";
var content_f10_2_10274=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Bullous tinea pedis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10274=[""].join("\n");
var outline_f10_2_10274=null;
var title_f10_2_10275="Azithromycin (ophthalmic): Pediatric drug information";
var content_f10_2_10275=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Azithromycin (ophthalmic): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?21/11/21683?source=see_link\">",
"    see \"Azithromycin (ophthalmic): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?13/42/13988?source=see_link\">",
"    see \"Azithromycin (ophthalmic): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7983203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      AzaSite&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10585100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Ophthalmic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F12824485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Gonococcal ophthalmia or chlamydial ophthalmia, prophylaxis (",
"      <i>",
"       Ophthalmia neonatorum",
"      </i>",
"      ):",
"     </b>",
"     Limited data available: 1-2  drops in each conjunctival sac; efficacy studies are lacking; however, may consider use during shortages of erythromycin ophthalmic ointment (CDC, 2006)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10585146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/11/21683?source=see_link\">",
"      see \"Azithromycin (ophthalmic): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Bacterial conjunctivitis:",
"     </b>",
"     Children &ge;1 year and Adults: Instill 1 drop in the affected eye(s) twice daily (8-12 hours apart) for 2 days, then 1 drop once daily for 5 days.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F7983372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic [drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     AzaSite&reg;: 1% (2.5 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F7983206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10585147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For topical ophthalmic use only. Avoid contacting tip with skin or eye. Invert closed bottle and shake once before each use. Remove cap with bottle inverted. Tilt head back and gently squeeze inverted bottle to instill drop.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F10585144\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store sealed bottle at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F). Once bottle is opened, store in refrigerator for &le;14 days; discard any remaining solution after 14 days.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10585101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of bacterial conjunctivitis due to susceptible CDC coryneform group G,",
"     <i>",
"      H. influenzae",
"     </i>",
"     ,",
"     <i>",
"      S. aureus",
"     </i>",
"     ,",
"     <i>",
"      S. mitis",
"     </i>",
"     group, or",
"     <i>",
"      S. pneumoniae",
"     </i>",
"     (FDA approved in ages &ge;1 year and adults); has also been used for",
"     <i>",
"      Ophthalmia neonatorum",
"     </i>",
"     prophylaxis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F7983166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Azithromycin may be confused with azathioprine, erythromycin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F7983238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Eye irritation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Abnormal taste, blurred vision, contact dermatitis, corneal erosion, dry eyes, eye pain, facial edema, hives, nasal congestion, ocular reactions (burning, discharge, irritation, itching, stinging), periocular swelling, punctate keratitis, rash, sinusitis, urticaria, visual acuity decreased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10585102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to azithromycin or any component, erythromycin, other macrolide, or ketolide antibiotics",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F15513560\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For topical ophthalmic use only; do not inject subconjunctivally or introduce directly into the anterior chamber of the eye.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F15513559\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Severe hypersensitivity reactions, including anaphylaxis, angioedema, and dermatologic reactions, have been reported with systemic use of azithromycin. Prolonged use may lead to overgrowth of nonsusceptible organisms, including fungi. Discontinue use and institute alternative therapy if superinfection is suspected. Contains benzalkonium chloride which may be absorbed by contact lenses; contact lens should not be worn during treatment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9770050\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F8043203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9800529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. The amount of azithromycin available systemically following topical application of the ophthalmic drops is estimated to be below quantifiable limits. Systemic absorption would be required in order for azithromycin to cross the placenta and reach the fetus. When administered orally or I.V., azithromycin crosses the placenta. Refer to the Azithromycin (Systemic) monograph for details.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10585145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial RNA-dependent protein synthesis by binding to the 50S ribosomal subunit which results in the blockage of transpeptidation",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F10585148\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/42/13988?source=see_link\">",
"      see \"Azithromycin (ophthalmic): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Advise patients who are being treated for bacterial conjunctivitis not to wear contact lenses.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Center for Disease Control and Prevention (CDC), &ldquo;CDC Guidance on Shortage of Erythromycin (0.5%) Ophthalmic Ointment,&rdquo; Available at",
"      <a href=\"file://www.cdc.gov/std/treatment/2006/erythromycinOintmentShortage.htm\" target=\"_blank\">",
"       file://www.cdc.gov/std/treatment/2006/erythromycinOintmentShortage.htm",
"      </a>",
"      . Date accessed: May 13, 2011 .",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15942 Version 24.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-41.222.196.37-1E842E28B5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10275=[""].join("\n");
var outline_f10_2_10275=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7983203\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10585100\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12824485\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10585146\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7983372\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7983206\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10585147\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10585144\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10585101\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7983166\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7983238\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10585102\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15513560\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15513559\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298804\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9770050\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8043203\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9800529\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10585145\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10585148\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15942\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15942|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/11/21683?source=related_link\">",
"      Azithromycin (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/42/13988?source=related_link\">",
"      Azithromycin (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17817?source=related_link\">",
"      Azithromycin (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?32/51/33589?source=related_link\">",
"      Azithromycin (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/3/6200?source=related_link\">",
"      Azithromycin (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_2_10276="Achalasia PA Lat";
var content_f10_2_10276=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Achalasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    PA and lateral chest x-rays from a patient with achalasia. The major findings are a widened mediastinum caused by the dilated esophagus, an air-fluid level in the upper chest due to retained fluid in the dilated esophagus (arrows), and absence of the gastric air bubble.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced, courtesy of the Clinical Teaching Project of the American Gastroenterological Association&copy;. This slide cannot be downloaded but may be purchased as part of a set from the AGA through Milner-Fenwick, Inc. at 1-800-432-8433.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10276=[""].join("\n");
var outline_f10_2_10276=null;
var title_f10_2_10277="Isosorbide dinitrate and hydralazine: Patient drug information";
var content_f10_2_10277=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Isosorbide dinitrate and hydralazine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/11/41141?source=see_link\">",
"     see \"Isosorbide dinitrate and hydralazine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F786631\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      BiDil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029800\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691384",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help a weak heart.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702334",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to isosorbide dinitrate, hydralazine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698255",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029807\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698621",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure lasting more than 15 minutes.",
"       <b>",
"        Get emergency medical care right away.",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698967",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain or swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10167335\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11172 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-5088ACF45B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10277=[""].join("\n");
var outline_f10_2_10277=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F786631\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029798\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029800\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029799\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029804\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029805\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029807\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029802\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029803\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10167335\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029809\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?40/11/41141?source=related_link\">",
"      Isosorbide dinitrate and hydralazine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_2_10278="Intradecidual sign";
var content_f10_2_10278=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F52770&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F52770&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intradecidual sign",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 463px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Sagittal and B) transverse views of the endometrial cavity. There is an eccentrically located fluid collection abutting the endometrium with echogenic rim (arrowhead) representing the intradecidual sign.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tejas S Mehta, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10278=[""].join("\n");
var outline_f10_2_10278=null;
var title_f10_2_10279="Zonisamide: Drug information";
var content_f10_2_10279=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Zonisamide: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?34/25/35221?source=see_link\">",
"    see \"Zonisamide: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/52/25415?source=see_link\">",
"    see \"Zonisamide: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F236246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Zonegran&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F236266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anticonvulsant, Miscellaneous",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F236250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Adjunctive treatment of partial seizures:",
"     </b>",
"     Oral: Initial: 100 mg/day. Dose may be increased to 200 mg/day after 2 weeks. Further dosage increases to 300 mg and 400 mg/day can then be made with a minimum of 2 weeks between adjustments, in order to reach steady state at each dosage level. Doses of up to 600 mg/day have been studied, however, there is no evidence of increased response with doses &gt;400 mg/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Mania (unlabeled use):",
"     </b>",
"     Oral: Initial: 100-200 mg/day; maximum: 600 mg/day (Kanba, 1994)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F236258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/52/25415?source=see_link\">",
"      see \"Zonisamide: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &gt;16 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F236251\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Data from clinical trials is insufficient for patients older than 65. Begin dosing at the low end of the dosing range.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F236252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Slower titration and frequent monitoring are indicated in patients with renal disease. Use is not recommended in patients with GFR &lt;50 mL/minute. Marked renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;20 mL/minute) was associated with a 35% increase in AUC.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F236253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Slower titration and frequent monitoring are indicated.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F236224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 25 mg, 50 mg, 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zonegran&reg;: 25 mg, 100 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F236209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM152828.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM152828.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F236227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Capsules should be swallowed whole. Dose may be administered once or twice daily. Doses of 300 mg/day and higher are associated with increased side effects. Steady-state levels are reached in 14 days.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F236225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunct treatment of partial seizures in children &gt;16 years of age and adults with epilepsy",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F236262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bipolar disorder",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F6790269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Zonegran&reg; may be confused with SINEquan&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Zonisamide may be confused with lacosamide",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F236264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequencies noted in patients receiving other anticonvulsants:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Somnolence (17%), dizziness (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Anorexia (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (10%), agitation/irritability (9%), fatigue (8%), tiredness (7%), ataxia (6%), confusion (6%), concentration decreased (6%), memory impairment (6%), depression (6%), insomnia (6%), speech disorders (5%), mental slowing (4%), anxiety (3%), nervousness (2%), schizophrenic/schizophreniform behavior (2%), difficulty in verbal expression (2%), status epilepticus (1%), seizure (1%), hyperesthesia (1%), incoordination (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (3%), bruising (2%), pruritus (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (9%), abdominal pain (6%), diarrhea (5%), dyspepsia (3%), weight loss (3%), constipation (2%), taste perversion (2%), xerostomia (2%), vomiting (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia (4%), abnormal gait (1%), tremor (1%), weakness (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Diplopia (6%), nystagmus (4%), amblyopia (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Tinnitus (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Kidney stones (4%, children 3% to 8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Rhinitis (2%), pharyngitis (1%), increased cough (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome (4%) accidental injury (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life threatening): Agranulocytosis, allergic reaction, alopecia, amenorrhea, aplastic anemia, apnea, arthritis, atrial fibrillation, bladder calculus, bradycardia, cerebrovascular accident, cholangitis, cholecystitis, cholestatic jaundice, colitis, deafness, duodenitis, encephalopathy, fecal incontinence, gingivitis, GI ulcer, glaucoma, heart failure, hematuria, hemoptysis, hirsutism, hyper-/hypotension, hyperthermia, hypoglycemia, hyponatremia, immunodeficiency, impotence, iritis, leukopenia, lupus erythematosus, lymphadenopathy, mastitis, menorrhagia, metabolic acidosis, neuropathy, oculogyric crisis, oligohidrosis (children), pancreatitis, photophobia, pulmonary embolus, rectal hemorrhage, Stevens-Johnson syndrome, stroke, suicidal behavior/ideation, syncope, thrombocytopenia, thrombophlebitis, toxic epidermal necrolysis, urinary incontinence, ventricular extrasystoles",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F236230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to zonisamide, sulfonamides, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F236213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects:  Significant CNS effects include psychiatric symptoms, psychomotor slowing, and fatigue or somnolence; fatigue and somnolence occur within the first month of treatment, most commonly at doses of 300-500 mg/day. May cause sedation, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Metabolic acidosis: Use may be associated with the development of metabolic acidosis (generally dose-dependent) in certain patients; predisposing conditions/therapies include renal disease, severe respiratory disease, diarrhea, surgery, ketogenic diet, and other medications. Serum bicarbonate should be monitored prior to initiation and during therapy; if metabolic acidosis occurs, consider decreasing the dose or tapering the dose to discontinue. If use continued despite acidosis, alkali treatment should be considered. Untreated metabolic acidosis may increase the risk of developing nephrolithiasis, nephrocalcinosis, osteomalacia, or osteoporosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal calculus: Discontinue therapy in patients who develop acute renal failure or a significant sustained increase in creatinine/BUN concentration; kidney stones have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Suicidal ideation: Pooled analysis of trials involving various antiepileptics (regardless of indication) showed an increased risk of suicidal thoughts/behavior (incidence rate: 0.43% treated patients compared to 0.24% of patients receiving placebo); risk observed as early as 1 week after initiation and continued through duration of trials (most trials &le;24 weeks). Monitor all patients for notable changes in behavior that might indicate suicidal thoughts or depression; notify healthcare provider immediately if symptoms occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfonamide reactions: Rare, but potentially fatal sulfonamide reactions have occurred following use. These reactions include Stevens-Johnson syndrome, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, and toxic epidermal necrolysis, usually appearing within 2-16 weeks of drug initiation; discontinue if rash develops. Chemical similarities are present among sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, and loop diuretics (except ethacrynic acid). Use in patients with sulfonamide allergy is specifically contraindicated in product labeling, however, a risk of cross-reaction exists in patients with allergy to any of these compounds; avoid use when previous reaction has been severe.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Do not use in patients with renal impairment (GFR &lt;50 mL/minute).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects with other sedative drugs or ethanol may be potentiated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy  have not been established in children &lt;16 years of age. Decreased sweating (oligohydrosis) and hyperthermia requiring hospitalization have been reported in children. Pediatric patients may be at an increased risk and may have more severe metabolic acidosis. Untreated metabolic acidosis may increase the risk of developing rickets in children; pediatric patients may also have decreased growth rates.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: Anticonvulsants should not be discontinued abruptly because of the possibility of increasing seizure frequency; therapy should be withdrawn gradually to minimize the potential of increased seizure frequency, unless safety concerns require a more rapid withdrawal.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F236259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C19 (minor), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F236218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists: Carbonic Anhydrase Inhibitors may decrease the excretion of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Carbonic Anhydrase Inhibitors may decrease the excretion of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticonvulsants (Barbiturate): Carbonic Anhydrase Inhibitors may enhance the adverse/toxic effect of Anticonvulsants (Barbiturate). Specifically, osteomalacia and rickets.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticonvulsants (Hydantoin): Carbonic Anhydrase Inhibitors may enhance the adverse/toxic effect of Anticonvulsants (Hydantoin). Specifically, osteomalacia and rickets.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: Carbonic Anhydrase Inhibitors may increase the serum concentration of CarBAMazepine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carbonic Anhydrase Inhibitors: May enhance the adverse/toxic effect of other Carbonic Anhydrase Inhibitors. The development of acid-base disorders with concurrent use of ophthalmic and oral carbonic anhydrase inhibitors has been reported. Management: Avoid concurrent use of different carbonic anhydrase inhibitors if possible.  Monitor patients closely for the occurrence of kidney stones and with regards to severity of metabolic acidosis.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Flecainide: Carbonic Anhydrase Inhibitors may increase the serum concentration of Flecainide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May decrease the serum concentration of Zonisamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Carbonic Anhydrase Inhibitors may decrease the serum concentration of Lithium.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mefloquine: May diminish the therapeutic effect of Anticonvulsants. Mefloquine may decrease the serum concentration of Anticonvulsants. Management: Mefloquine is contraindicated for malaria prophylaxis in persons with a history of convulsions.  Monitor anticonvulsant concentrations and treatment response closely with concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Memantine: Carbonic Anhydrase Inhibitors may decrease the excretion of Memantine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MetFORMIN: Carbonic Anhydrase Inhibitors may enhance the adverse/toxic effect of MetFORMIN. Specifically, the risk of developing lactic acidosis may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methenamine: Carbonic Anhydrase Inhibitors may diminish the therapeutic effect of Methenamine.  Management: Consider avoiding this combination. Monitor for decreased therapeutic effects of methenamine if used concomitant with a carbonic anhydrase inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PHENobarbital: May decrease the serum concentration of Zonisamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May decrease the serum concentration of Zonisamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Primidone: Carbonic Anhydrase Inhibitors may enhance the adverse/toxic effect of Primidone. Specifically, osteomalacia and rickets. Carbonic Anhydrase Inhibitors may decrease the serum concentration of Primidone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Carbonic Anhydrase Inhibitors may decrease the excretion of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F236242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Food delays time to maximum concentration, but does not affect bioavailability.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F236220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F236232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were observed in animal reproduction studies; therefore, zonisamide is classified as pregnancy category C. Zonisamide crosses the placenta and can be detected in the newborn following delivery. Although adverse fetal events have been reported, the risk of teratogenic effects following maternal use of zonisamide in not clearly defined. Other agents may be preferred until additional data is available. Newborns should be monitored for transient metabolic acidosis after birth. Zonisamide clearance may increase in the second trimester of pregnancy, requiring dosage adjustment. Women of childbearing potential are advised to use effective contraception during therapy.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Patients exposed to zonisamide during pregnancy are encouraged to enroll themselves into the AED Pregnancy Registry by calling 1-888-233-2334. Additional information is available at file://www.aedpregnancyregistry.org.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F236255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excreted into breast milk /not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F236233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Zonisamide is excreted into breast milk in concentrations similar to those in the maternal plasma and has been detected in the plasma of a nursing infant. According to the manufacturer, the decision to continue or discontinue breast-feeding during therapy should take into account the risk of exposure to the infant and the benefits of treatment to the mother.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F236234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F3422286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Zonegran Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (100): $147.05",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $588.18",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Zonisamide Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (100): $54.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $109.60",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $219.20",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F236222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Metabolic profile, specifically BUN, serum creatinine; serum bicarbonate (prior to initiation and periodically during therapy); suicidality (eg, suicidal thoughts, depression, behavioral changes)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Excegran (JP, KP);",
"     </li>",
"     <li>",
"      Zonegran (AT, AU, BE, BG, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HN, ID, IE, IN, IT, MT, MY, NL, NO, PH, PT, RU, SE, SK, TH, TR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F236212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The exact mechanism of action is not known. May stabilize neuronal membranes and suppress neuronal hypersynchronization through action at sodium and calcium channels. Does not affect GABA activity.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F236229\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 1.45 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 40%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via CYP3A4; forms N-acetyl zonisamide and 2-sulfamoylacetyl phenol (SMAP)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Plasma: ~63 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: 2-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (62%, 35% as unchanged drug, 65% as metabolites); feces (3%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Kanba S, Yagi G, Kamijima K, et al, &ldquo;The First Open Study of Zonisamide, A Novel Anticonvulsant, Shows Efficacy in Mania,&rdquo;",
"      <i>",
"       Prog Neuropsychopharmacol Biol Psychiatry",
"      </i>",
"      , 1994, 18(4):707-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/2/10279/abstract-text/7938561/pubmed\" id=\"7938561\" target=\"_blank\">",
"        7938561",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kawada K, Itoh S, Kusaka T, et al, &ldquo;Pharmacokinetics of Zonisamide in Perinatal Period,&rdquo;",
"      <i>",
"       Brain Dev",
"      </i>",
"      , 2002, 24(2):95-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/2/10279/abstract-text/11891100/pubmed\" id=\"11891100\" target=\"_blank\">",
"        11891100",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kimura S, &ldquo;Zonisamide-Induced Behavior Disorder in Two Children,&rdquo;",
"      <i>",
"       Epilepsia",
"      </i>",
"      , 1994, 35(2):403-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/2/10279/abstract-text/8156965/pubmed\" id=\"8156965\" target=\"_blank\">",
"        8156965",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9862 Version 46.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-115.124.72.62-5A3D10F1CE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10279=[""].join("\n");
var outline_f10_2_10279=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236246\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236266\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236250\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236258\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236251\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236252\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236253\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236224\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236209\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874937\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236227\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236225\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236262\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6790269\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236264\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236230\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236213\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236259\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236218\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236242\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236220\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236232\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236255\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236233\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236234\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422286\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236222\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038858\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236212\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F236229\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9862\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9862|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?34/25/35221?source=related_link\">",
"      Zonisamide: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/52/25415?source=related_link\">",
"      Zonisamide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_2_10280="ECG Idiopathic left ventricular tachycardia";
var content_f10_2_10280=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 544px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) showing idiopathic left ventricular tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 524px; height: 355px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The typical ECG features of an idiopathic left ventricular tachycardia are QRS complexes that are relatively narrow (0.12 sec) and have a right bundle branch morphology (tall R waves in V1 and V2 and a terminal S wave in V5 and V6); the frontal plane axis is extremely leftward (negative QRS complexes in leads II, III and aVF), suggesting a left anterior fascicular block. The tachycardia was localized to the inferior apical left ventricular septum, accounting for the extreme leftward axis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10280=[""].join("\n");
var outline_f10_2_10280=null;
var title_f10_2_10281="Confidentiality in adolescent health care";
var content_f10_2_10281=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Confidentiality in adolescent health care",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/2/10281/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/2/10281/contributors\">",
"     Amy B Middleman, MD, MPH, MS Ed",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/2/10281/contributors\">",
"     Kelly A Olson, MD, MA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/2/10281/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/2/10281/contributors\">",
"     Abigail English, JD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/2/10281/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/2/10281/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/2/10281/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The concepts of informed consent and confidentiality are complex when the patient is an adolescent. This is particularly true when the needs and wishes of the adolescent conflict with the opinions and preferences of the parents [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The laws governing consent and confidentiality in adolescent health care vary from country to country; within the United States, they vary from state to state. The information in this topic focuses on confidentiality in adolescent health care in the United States.",
"   </p>",
"   <p>",
"    Clinicians who treat adolescents must be aware of the federal and state laws related to adolescent consent and confidentiality. The circumstances in which adolescents may consent for their own care and confidentiality vary from state to state depending upon the adolescent's status as a minor or adult, the service involved, and the provider's level of concern regarding harm to the patient or others.",
"   </p>",
"   <p>",
"    The basic laws governing consent for health care are state laws; clinicians who treat adolescents need to be aware of the laws in their state. Confidentiality provisions are found in both state and federal law. Clinicians who treat adolescents also must be aware that federal and state funding source regulations may contain specific requirements related to confidentiality for particular services. They should be familiar with the consent and confidentiality policies of the facility in which they practice, and they must be aware of potential ways in which confidentiality can be compromised (eg, record keeping, billing statements, insurance).",
"   </p>",
"   <p>",
"    This topic will provide an overview of confidentiality in adolescent health care, including definitions, exceptions to confidentiality, and potential threats to confidentiality. Determination of minor status and how it relates to consent for specific medical services, which is closely linked to confidentiality, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5512?source=see_link\">",
"     \"Consent in adolescent health care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of independence from parents is an important task of adolescence [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. It includes the gradual assumption of responsibility for personal health, health behaviors, and medical decisions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/2,3,5,6\">",
"     2,3,5,6",
"    </a>",
"    ]. Confidentiality protection is essential to this process.",
"   </p>",
"   <p>",
"    Adolescents are more likely to seek health care if they believe their provider will keep the information discussed during the visit private [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/7-11\">",
"     7-11",
"    </a>",
"    ]. Concerns regarding lack of confidentiality protection may cause some adolescents to go without health care [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The importance of confidentiality to adolescents was illustrated in a survey of high school students who were randomly assigned to one of three groups that listened to an audiotape of a clinician assuring unconditional confidentiality (confidentiality would not be violated under any circumstances), conditional confidentiality (confidentiality would be violated if there was risk of harm to the patient or another), or not mentioning confidentiality [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/10\">",
"     10",
"    </a>",
"    ]. Adolescents in the groups that were assured confidentiality reported greater willingness to disclose sensitive information (eg, sexuality, substance use, and mental health) (47 versus 39 percent) and to seek future health care (67 versus 53 percent) than those in the group where confidentiality was not mentioned.",
"   </p>",
"   <p>",
"    This information notwithstanding, many health care providers do not routinely discuss confidentiality with adolescent patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/8,12\">",
"     8,12",
"    </a>",
"    ]. Although most clinicians support the concept of providing confidential care to adolescents, the level of support may vary depending upon the type of service provided and provider comfort [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/2,13\">",
"     2,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONFIDENTIALITY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Confidentiality refers to the \"privileged and private nature of information provided during the health care transaction\" [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/5\">",
"     5",
"    </a>",
"    ]. It should be discussed with the patient and his or her parents or legal guardian at the initial adolescent visit (",
"    <a class=\"graphic graphic_table graphicRef70738 \" href=\"UTD.htm?42/30/43499\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/2,6,14\">",
"     2,6,14",
"    </a>",
"    ]. It is important to discuss both what will not be divulged by the provider and what must be divulged by the provider (eg, \"conditional\" versus \"unconditional\" confidentiality, defined below) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although it is important for clinicians to respect their adolescent patients' privacy and the confidentiality of their patients' information, it is also important to encourage the adolescent, when appropriate, to talk with his or her parents about these personal and sensitive issues that affect health even if doing so may be uncomfortable [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/3,5,6,15\">",
"     3,5,6,15",
"    </a>",
"    ]. Parental support can help to ensure that the adolescent's health needs are met [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The trust that develops between the provider and adolescent patient surrounding issues of confidentiality can improve adolescent health care and help adolescents view the health-care system as a place to which they can go for help throughout their lives. In providing confidential care, it is important to balance the needs of the patient, parents, and provider [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/3\">",
"     3",
"    </a>",
"    ]. Providers who are uncomfortable providing confidential care to competent adolescents may choose to refer the adolescent to another provider where confidential services are offered [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/15,17\">",
"     15,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some states give clinicians the option to inform parents their child is seeking services related to sexual health care, substance abuse, and mental health care. In these states, the decision of informing the parents is left to the clinician's discretion and what he or she considers to be in the best interest of the minor or necessary for the minor's health [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/18\">",
"     18",
"    </a>",
"    ]. In some cases, family involvement may be essential to the treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/14,19\">",
"     14,19",
"    </a>",
"    ]. As an example, if an adolescent has not come to critical follow-up appointments pertaining to a confidential health issue, a provider may decide that family involvement is an important tool needed to protect the adolescent's health.",
"   </p>",
"   <p>",
"    The decision to violate confidentiality and disclose information should be undertaken after careful consideration and with the intent of beneficence. If the clinician intends to disclose information, he or she should discuss the reasons for disclosure with the patient and allow the patient to participate in the decision of to whom and in what manner the information should be told [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In other cases (eg, seriously dysfunctional parent-child relationships), parental involvement is potentially harmful to the adolescent (eg, places them at risk for being forced out of the home, being forced into unwanted marriage, or physical abuse) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/15\">",
"     15",
"    </a>",
"    ]. These situations highlight the importance of confidentiality pertaining to adolescent health care. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5512?source=see_link&amp;anchor=H14#H14\">",
"     \"Consent in adolescent health care\", section on 'Consent for specific services'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Conditional versus unconditional",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend that clinicians who care for adolescent patients discuss confidentiality with the patient and his or her parents or guardians at the beginning of the adolescent-provider relationship, explicitly defining the circumstances under which confidentiality is \"conditional\" or must be broken. Provision of such \"conditional\" confidentiality is recommended by professional organizations and protected by law [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/5,20\">",
"     5,20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Exceptions to confidentiality'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    With conditional confidentiality, the clinician assures the patient that everything that is discussed will be kept private except when disclosure is required by law, such as in situations of abuse, suicidal ideation, or homicidal ideation; the patient also must be informed that certain sexually transmitted infections (STIs) are reportable to public health departments. In addition, many providers add that behaviors representing a serious threat to patient safety may warrant disclosure to parents. As an example, if a patient is drinking a large quantity of alcohol before driving a car on a regular basis, and the patient",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    provider determine that immediate change is not possible, this would be a serious threat to patient safety for which parental help might be enlisted. It is critical to present the conditions in a way that assure the patient that safety and concern are the driving forces, not control and punishment. The following is an example of how to convey conditional confidentiality:",
"   </p>",
"   <p>",
"    \"I want you to understand that when we talk about things that have to do with sex and drugs and your feelings, it is confidential. This means that what we talk about is just between you and me and that other people, including your parents, will not find out about it unless you want them to know. One exception to this is if I am concerned someone has abused or hurt you. Another exception is if I am concerned you are at serious risk of harm or are planning to or behaving as though you may hurt yourself or someone else. In these situations, I would have to talk to other adults, but I would talk to you first so we could figure out whom we should talk to and the best way to handle it\" [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some clinicians who discuss confidentiality with their adolescent patients promise \"unconditional\", rather than \"conditional\", confidentiality [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/12\">",
"     12",
"    </a>",
"    ]. A promise of unconditional confidentiality implies that everything that is discussed will be kept private from the parents or anyone else unless the patient wants them to know.",
"   </p>",
"   <p>",
"    Although it may not be their intention, clinicians may convey a promise of unconditional confidentiality by not being explicit about the conditions under which confidentiality may be broken; unconditional confidentiality is conveyed in the following example:",
"   </p>",
"   <p>",
"    \"I want you to understand that when we talk about things that have to do with sex and drugs and your feelings, it is confidential. This means that what we talk about is just between you and me and that other people, including your parents, will not find out about it unless you want them to know\" [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A promise of unconditional confidentiality is not in accordance with the guidelines set forth by professional organizations, which recommend discussion of conditional confidentiality with the teen and his or her parents. In addition, \"unconditional\" confidentiality is outside the legal boundaries of confidentiality protection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/5,20\">",
"     5,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nonetheless, statements assuring conditional confidentiality may affect the adolescent's willingness to return for future health care. In the survey described above, in which high school students were randomly assigned to listen to an audiotape of a clinician assuring unconditional confidentiality, conditional confidentiality, or not mentioning confidentiality, those who heard the tape assuring unconditional confidentiality reported greater willingness to return for a future visit than those who heard the tape assuring conditional confidentiality (72 versus 62 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One explanation for this finding is that adolescents are unable to distinguish between the confidentiality granted to routine health issues that can be managed solely by the clinician and that granted to serious issues that require outside assistance for management (eg, abuse, suicide) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/10\">",
"     10",
"    </a>",
"    ]; therefore, any mention of \"exceptions\" to confidentiality causes the teen to worry that his or her confidentiality will be violated unnecessarily [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/10\">",
"     10",
"    </a>",
"    ]. The provider who understands this can help assuage unnecessary fears by providing a clear explanation of the conditions under which confidentiality will need to be breached.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12770562\">",
"    <span class=\"h2\">",
"     Public health perspective",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, confidentiality protects the individual patient. From the public health perspective, however, some confidentiality laws that restrict access to data &mdash; especially population-based data, such as immunization registries and other large databases &mdash; may impede research efforts and gains. These laws pertain even when data are de-identified within the database. Thus, a huge epidemiologic resource is lost based solely on the implementation and enforcement of laws that were instituted to protect the very individuals who could benefit from the research conducted on the data. As we move forward with the development of these substantial and valuable databases made possible by the electronic age, the public health community must advocate for a change in the confidentiality policies pertaining to the de-identified data in order to allow for effective public health research [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EXCEPTIONS TO CONFIDENTIALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within the context of the provider-patient relationship, it is critical that the clinician explain the legal, clinical, and ethical limits of confidentiality [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/22\">",
"     22",
"    </a>",
"    ]. If a parent or other adult is involved in the treatment of an adolescent patient, he or she should be included in this discussion. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Conditional versus unconditional'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition to state regulations that require reporting of certain events or conditions (eg, child abuse, knife or gunshot wounds, sexually transmitted infections), confidentiality may be violated by laws that grant parents explicit access to the minors' complete medical records [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Potential threats to confidentiality'",
"    </a>",
"    below.) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Child abuse/neglect",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians must report suspected or confirmed sexual or physical abuse or neglect of a child to appropriate authorities. Irrefutable proof is not necessary to trigger the reporting requirement, only suspicion. The minor should not be allowed to leave with or return to the parent or guardian if the parent or guardian is suspected of perpetrating the abuse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link\">",
"     \"Evaluation of sexual abuse in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/15/11510?source=see_link\">",
"     \"Management and sequelae of sexual abuse in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18408?source=see_link\">",
"     \"Child neglect and emotional abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Consensual sexual activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;State requirements for reporting sexual abuse and sexual activity vary. Every state has laws that require the reporting of sexual abuse and laws that specify when sexual activity with a minor or between minors is illegal (eg, sometimes called \"statutory rape\") [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/16,23\">",
"     16,23",
"    </a>",
"    ]. Depending upon the state, consensual sexual activity between two 17-years-olds, two 13-year-olds, or a 14-year-old and a 17-year-old may or may not be considered illegal and may or may not be reportable as child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The laws vary widely in terms of whether consensual sexual activity involving a minor is considered child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/16,24\">",
"     16,24",
"    </a>",
"    ]. Many state laws consider sexual activity between an adult and a minor to be abuse. These laws assume that all sexual activities involving individuals younger than a certain age are by definition coercive, even if both parties consider the activity to be voluntary [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/23\">",
"     23",
"    </a>",
"    ]. In such states, parents can be reported for abuse or neglect if they are aware of their minor's consensual sexual relationship and assist him or her in obtaining reproductive health care [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The statutes for consensual intercourse typically incorporate the ages of, or difference in age between, the patient and his or her partner(s) and whether the older person is in a position of authority; they also may include specific types of sexual behavior (fondling versus oral-genital contact versus anal or vaginal penetration) and, in some states, sex of the partner (eg, Texas law) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The requirement to report statutory rape is dictated by the state's definition of child abuse; statutory rape is not always a reportable offense. In approximately one-third of states, reporting of statutory rape is mandated only if it was committed or allowed by a person responsible for the care of the child [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/23\">",
"     23",
"    </a>",
"    ]. In the remaining two-thirds of states, reporting mandates are independent of the relationship between the involved parties. The guidelines for the reporting of statutory rape in individual states are usually found in the section of criminal code dedicated to child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is the view of the American Academy of Family Physicians, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and the Society for Adolescent Medicine that sexual activity is not synonymous with sexual abuse, that access to confidential health care is essential for adolescents, and that the vast majority of reportable cases of sexual abuse and sexual coercion can be identified through careful clinical assessment [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link\">",
"     \"Evaluation of sexual abuse in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Factors to be considered in this assessment include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Whether the adolescent is in a sexual relationship with a family member, person of authority, or member of the clergy",
"     </li>",
"     <li>",
"      The adolescent's ability to comprehend, make informed decisions about, or consent to sexual activity (eg, whether he or she",
"      <span class=\"nowrap\">",
"       was/is",
"      </span>",
"      incapacitated by mental illness, intellectual disability [mental retardation], drugs, alcohol)",
"     </li>",
"     <li>",
"      Whether the sexual relationship involves violence or coercion.",
"     </li>",
"     <li>",
"      The age of the adolescent and the degree to which he or she understands the consequences and responsibilities of sexual activity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nonetheless, health care providers have a legal duty to report cases of sexual abuse to the proper authority in accordance with the laws of their state [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/16,24\">",
"     16,24",
"    </a>",
"    ]. This legal duty may be in conflict with their ethical obligation to maintain their patient's confidentiality",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    their ability to exercise sound medical judgment [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/16,24\">",
"     16,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Suicidal ideation or attempt",
"    </span>",
"    &nbsp;&mdash;&nbsp;When an adolescent is at risk for harming himself or herself, confidentiality must be breached in deference to the safety of the patient [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/25\">",
"     25",
"    </a>",
"    ]. When a patient reports suicidal ideation, particularly if he or she has a history of suicide attempt, it is critical to keep him or her safe until the suicidal state diminishes or abates. This usually involves working with the family or other supportive individuals who can address safety concerns (eg, remove access to means) and are willing to stay with the child or adolescent at all times. Immediate psychiatric evaluation (through the emergency department or psychiatry crisis clinic)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hospitalization may be warranted [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/11/38071?source=see_link\">",
"     \"Evaluation and management of suicidal behavior in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In such circumstances, the clinician should discuss the need to violate confidentiality with the patient. The discussion should include formulation of a plan regarding whom should be told and how the disclosure should be made.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Homicidal ideation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one-half of states have statutes that require mental health care providers to disclose a patient's intent to do harm by warning the victim [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/27\">",
"     27",
"    </a>",
"    ]. These laws are based upon a California Supreme Court decision in a case where a patient told his psychotherapist that he intended to kill a woman and subsequently killed her (Tarasoff versus the Regents of the University of California) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/28\">",
"     28",
"    </a>",
"    ]. The California Supreme Court determined that when a therapist determines (or should have determined based upon the standards of the profession) that a patient poses a serious danger of violence to an identified victim, the therapist has a duty to use reasonable care to protect the intended victim.",
"   </p>",
"   <p>",
"    Many primary care providers feel the same duty to report patient homicidal ideation. In one case where a primary health clinician warned a third party of possible danger, he was sued by his patient but not held liable because the courts thought he had a \"legal duty\" to inform the potential victim [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Violent injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians are required to report all wounds inflicted by stabbing or gunshot, regardless of patient age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Sexually transmitted infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexually transmitted infections (STIs) must be reported to public health departments since they are communicable diseases. Follow-up of these reports is done confidentially and typically only involves patients with syphilis and HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/22\">",
"     22",
"    </a>",
"    ]. In some states, the finding of an STI or pregnancy in a minor patient requires screening with documentation for sexual abuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Mental health care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mental health care providers have long been mandated to break confidentiality in instances where there is threatened harm to self or others [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Suicidal ideation or attempt'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H10\">",
"     'Homicidal ideation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition, pediatric care providers may feel ethically obligated to break confidence and inform parents about an adolescent's risky behavior if the behavior would result in injurious outcomes. Although most adolescents engage in some risky",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    compromising behavior, the provider must use his or her professional judgment to determine at what point the frequency",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    duration of the behavior is a threat to the safety of the patient or to others [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Parental notification",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some states, parental notification is mandatory when a minor patient consents to certain health services (typically abortion); in others, it is permitted when it is determined by the clinician to be in the best interest of the patient; and in still others it is not acceptable to betray confidentiality without a good cause. When parental notification is going to occur, the adolescent should be informed that parental notification is going to occur and why it is necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/15\">",
"     15",
"    </a>",
"    ]. He or she should participate in the decision of to whom and in what manner the information should be told.",
"   </p>",
"   <p>",
"    The adolescent's perception of parental notification for prescription contraception was evaluated in a national survey of 1526 female adolescents attending family planning clinics [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/9\">",
"     9",
"    </a>",
"    ]. Among the adolescents surveyed, 60 percent reported their parent or guardian knew they were seeking reproductive health care, and 59 percent reported they would continue to use prescription contraception even if their parent or guardian were notified. Others would use nonprescription contraception or go to a private clinician. Only 1 percent reported they would stop having sex as a response to parental notification.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     POTENTIAL THREATS TO CONFIDENTIALITY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Medical records",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical (or electronic) medical record belongs to the clinician, practice, or institution that is responsible for maintaining it, not to the parent. Nonetheless, the confidentiality of adolescent patients may be inadvertently breached through documentation of their health care visits. Many health-care providers do not distinguish between information that is confidential &mdash; either based upon legal protections or ethical principles &mdash; and nonconfidential information when they document (ie, they may document confidential health behaviors on the same page as the physical examination without specifying that such information is confidential) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/2\">",
"     2",
"    </a>",
"    ]. When parents request copies of the medical record (eg, for transfer to a new provider or referral to a specialist), they generally receive the entire medical record [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One way that providers can avoid this scenario is to transfer records directly to the new provider or referral source, rather than to the parent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/2\">",
"     2",
"    </a>",
"    ]. Another is for the provider to distinguish between confidential and nonconfidential information, which makes it easier to redact the confidential portions before the medical record is released to the parent.",
"   </p>",
"   <p>",
"    The ability to redact information and to segregate confidential from other information in a medical chart depends upon the policies of a particular institution or practice setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     HIPAA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The health privacy regulations (sometimes referred to as the HIPAA Privacy Rule) issued under the Health Insurance Portability and Accountability Act (",
"    <a class=\"external\" href=\"file://www.hhs.gov/ocr/privacy/\">",
"     HIPAA",
"    </a>",
"    ) of 1996, which took effect in 2002, provide important protection for minors. Under HIPAA, adolescents who are legal adults (18 years and older) and minors who are emancipated can exercise the rights of \"individuals\", which grants them access to their medical records, the ability to obtain copies and to request corrections, and the right to authorize disclosure of protected health information. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5512?source=see_link&amp;anchor=H4#H4\">",
"     \"Consent in adolescent health care\", section on 'Emancipated minor'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Minors who are not emancipated have a \"personal representative\", usually their parent or guardian, who has the right to make health care decisions for them, and that personal representative has access to their personal health information or records. However, under the rule, a minor is considered as an \"individual\" in three specific situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When the minor has the right to consent to health care (eg, for treatment of an STI, request for birth control, treatment for substance abuse) and does consent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5512?source=see_link\">",
"       \"Consent in adolescent health care\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When the minor may legally receive care without parental consent and the minor or a third party, such as a court, can consent to the care (eg, when a minor goes through a judicial bypass proceeding to obtain an abortion without parental involvement). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5512?source=see_link&amp;anchor=H21#H21\">",
"       \"Consent in adolescent health care\", section on 'Judicial bypass'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When a parent is in agreement with a statement of confidentiality between the health care provider and the minor, which should be formally documented in the patient's records (",
"      <a class=\"graphic graphic_figure graphicRef67285 \" href=\"UTD.htm?30/0/30720\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the above situations, the parent is not a personal representative and does not automatically have access to the minor's records and personal health information. With respect to anyone other than a parent, the minor has the same rights with respect to his or her records as any other adult individual. With respect to the question of whether parents have access to the information, the rule defers to \"state or other applicable law\" [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Disclosure of information to parents when the minor is considered an \"individual\" under the rule is deferred to specific federal or state laws, or, in some cases, to the judgment of the provider. If state or other law explicitly requires information to be disclosed to the parent, the provider must do so. If state or other law prohibits disclosure of information to parents without the permission of the minor, the provider must honor that. If a state or other law permits, but does not explicitly require, the disclosure of information, the provider must use his or her own judgment in determining whether disclosure is in the best interest of the patient. If there is no state or other law regarding disclosure, it is again up to the discretion of the provider whether disclosure is appropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Under HIPAA guidelines, a minor acting as an \"individual\" may request that providers and health care plans communicate with him or her in a confidential manner (eg, e-mail or personal cell phone). He or she also can request that the information disclosed for treatment, payment, or other services be limited [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/32\">",
"     32",
"    </a>",
"    ]. Unfortunately, this request may not always be honored, sometimes because of oversight, and sometimes because the provider or third-party payer is unaware of this legal provision and has not set up procedures for honoring it.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     FERPA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Family Educational Rights and Privacy Act (FERPA) allows parents access to their unemancipated minor's educational records. If these records contain any health information, that information is also accessible by the parents. However, if the health records are kept separately as part of a school-based health center, where confidentiality has been addressed, these records cannot be accessed as part of FERPA. Instead, they would be covered by HIPAA, and the parents may or may not have access, depending upon the state laws governing the minor's ability to consent to health care and the confidentiality of information and records pertaining to that care [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'HIPAA'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Electronic records",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electronic medical record is another potential area where the confidentiality of an adolescent patient could be breached. The records for a particular visit should be accessible only by those who need to know the details [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Each state has its own laws regarding the confidential treatment of adolescents. When choosing an electronic medical record system, it is important to consider whether the system complies with or can be adapted to comply with the requirements of the state and individual practice regarding confidentiality [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. This is particularly true when documenting sexual health, mental health, and behavioral issues. Some systems address this issue by restricting access to visit records to the \"authoring\" department, avoiding the possibility that another provider may inadvertently have access to or reveal confidential information.",
"   </p>",
"   <p>",
"    Safeguards must be taken to prevent \"hacking\" into the electronic medical record by unauthorized individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/36\">",
"     36",
"    </a>",
"    ]. In addition, confidential electronic records should be reviewed by the treating provider before release to assure the preservation of patient confidentiality when appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Payment for services",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential for breach of confidentiality related to payment for health care services depends to some extent upon the method of payment and who is liable for payment and the method of payment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Who is liable?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment for which a nonemancipated minor consents is generally the financial responsibility of the minor [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/14\">",
"     14",
"    </a>",
"    ]. The parents are usually not financially liable unless they have agreed to pay for treatment, they are involved in the treatment decision, or the minor lives at home and the treatment is considered necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/37-39\">",
"     37-39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Emancipated minors also are typically financially responsible for the care to which they consent (whether or not it is emergent) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/38\">",
"     38",
"    </a>",
"    ]. The parents are unlikely to be liable unless they have agreed to pay.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Method of payment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Private insurance &ndash; To receive payment for services, clinicians are required to share medical information with third-party payers. The adult policy holder may choose to waive the right to confidentiality to ensure payment. If so, minor children covered by their parents' policy are bound by the same waiver, whether they know this is the case or not [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/36\">",
"       36",
"      </a>",
"      ]. Even though certain health care services can be performed without parental consent or notification, confidentiality may be breached when the bill or a detailed insurance statement is sent to the patient's parents [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/5,40\">",
"       5,40",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      To help protect the confidentiality of their minor patients, some clinics may choose to waive the fees for Papanicolaou smears, STI testing, and pregnancy tests, resulting in decreased income for the practice. Others refer their patients to facilities that offer free or reduced-fee services, potentially causing a disruption in the continuity of care [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/40\">",
"       40",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      One other option is to set up a self-payment plan with an adolescent patient. Adolescents sometimes are willing to pay for their health care if it protects their confidentiality and they can afford to do so [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/40,41\">",
"       40,41",
"      </a>",
"      ]. One private practice evaluated the possibility of providing adolescents with individual billing accounts to cover the charges that the adolescent wanted to keep confidential (eg, laboratory tests) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/40\">",
"       40",
"      </a>",
"      ]. Such accounts were offered to 42 patients, and 40 enrolled. The adolescent's account was charged a reduced fee for laboratory services (mean charge was $42, range $10 to $120); clinician charges were billed to insurance under nonconfidential codes. The patients agreed to pay whenever and whatever they could; at the end of the first three months, 38 percent of the total charges had been reimbursed.",
"     </li>",
"     <li>",
"      Medicaid &ndash; If a patient is funded by Medicaid, billing is confidential and sent directly to Medicaid, and statements generally are not sent to the parents, although there may be exceptions to this in some states, and clinicians should be familiar with policy and practice in their own state.",
"     </li>",
"     <li>",
"      Clinics funded by the Title X Family Planning Program &ndash; Patients who receive their care at Title X-funded clinics receive reproductive care on a confidential basis and are charged a sliding-scale fee based on the patient's &mdash; not the family's &mdash; income [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      State-funded programs &ndash; Regulations for state-funded reproductive health programs vary by state. Two states (Texas and Utah) prohibit a minor from receiving contraception without parental notification; other states allow notification of the parents [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      School-based clinics &ndash; School-based clinics usually require a general parental consent before provision of services. Typically, the parent is presented with a list of services offered by the clinic and made aware that some, but not all, of the services may be confidential. The clinics then follow the notification guidelines provided by their state and funding source.",
"      <br/>",
"      <br/>",
"      Parents may or may not have access to confidential information discussed during visits to school-based clinics. If the health records are maintained separately from the educational records, the health records are not provided to parents who request records under FERPA. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'FERPA'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Ancillary staff",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even if confidentiality is assured by the clinician, it may be violated by another provider or member of the clinician's staff. Individual practices should develop an official confidentiality policy and train all employees on its nuances [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Some clinicians create a written confidentiality agreement for the patient, parent(s), and provider to sign after discussing the confidentiality policy (",
"    <a class=\"graphic graphic_figure graphicRef67285 \" href=\"UTD.htm?30/0/30720\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Pharmacists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacists may refuse to fill a prescription for contraception for a minor without the consent of a parent, even if the prescription was provided confidentially and the state permits minors to consent for contraceptive services [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Pharmacist Conscience Clause created by the American Pharmaceutical Association (APhA) states that the APhA \"recognizes the individual pharmacist's right to exercise conscientious refusal and supports the establishment of systems to ensure patients' access to legally prescribed therapy without compromising the pharmacist's right of conscientious refusal\" [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/46\">",
"     46",
"    </a>",
"    ]. State regulations regarding pharmacist conscience clauses and refusal to provide contraceptive services vary from state to state (see",
"    <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/spibs/spib_RPHS.pdf\">",
"     www.guttmacher.org/statecenter/spibs/spib_RPHS.pdf",
"    </a>",
"    and",
"    <a class=\"external\" href=\"file://www.ncsl.org/programs/health/conscienceclauses.htm\">",
"     www.ncsl.org/programs/health/conscienceclauses.htm",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The attitudes toward and practice of pharmacists were evaluated in a survey of pharmacists in Indiana (a state in which there was no law addressing the provision of contraception to minors) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/45\">",
"     45",
"    </a>",
"    ]. The pharmacists reported that they were more likely to contact a parent or provider before dispensing contraceptives to a 14-year-old than to a 17-year-old [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/45\">",
"     45",
"    </a>",
"    ]. Another survey noted that approximately 50 percent of pharmacists believed the following incorrect statements: that emergency contraception was harmful to adolescents, that oral contraceptive pills caused birth defects if taken during pregnancy, and that the repeated use of emergency contraception was associated with health risks [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resources related to consent and confidentiality in adolescent health care are provided below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/spibs/spib_OMCL.pdf\">",
"       Alan Guttmacher Institute",
"      </a>",
"      provides updated information regarding state policies for specific services",
"     </li>",
"     <li>",
"      The",
"      <a class=\"external\" href=\"file://www.cahl.org/\">",
"       Center for Adolescent Health &amp; the Law",
"      </a>",
"     </li>",
"     <li>",
"      The",
"      <a class=\"external\" href=\"file://www.jlc.org/index.php/factsheets/emancipationus\">",
"       Juvenile Law Center",
"      </a>",
"      provides information regarding the emancipation laws in individual states",
"     </li>",
"     <li>",
"      The National Conference of State Legislatures provides information on a number of related topics, including:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.ncsl.org/issues-research/health/pharmacist-conscience-clauses-laws-and-information.aspx\">",
"       Pharmacist conscience clauses",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.ncsl.org/issues-research/health/emergency-contraception-state-laws.aspx\">",
"       Emergency contraception",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.ncsl.org/issues-research/health/immunizations-policy-issues-overview.aspx\">",
"       Immunization legislation",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.ncsl.org/issues-research/health/hpv-vaccine-state-legislation-and-statutes.aspx\">",
"       Human papillomavirus legislation",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adolescents are more likely to seek health care if they believe their provider will keep the information discussed during the visit private. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Confidentiality refers to the \"privileged and private nature of information provided during the health care transaction\" [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10281/abstract/5\">",
"       5",
"      </a>",
"      ]. It should be discussed with the patient and his or her parents or legal guardian at the initial adolescent visit. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although it is important for clinicians to respect their adolescent patients' confidentiality, it is also important to encourage the adolescent to talk with his or her parents about issues that affect health. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that clinicians who care for adolescent patients discuss \"conditional\" confidentiality with the patient and his or her caregivers, explicitly defining the circumstances under which confidentiality must be broken. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Conditional versus unconditional'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Exceptions to confidentiality include mandated reporting (eg, child abuse, violent injuries, sexually transmitted infections) and mandatory parental notification. Some states also permit parental notification for specific services if the health care provider believes it is in the best interest of the patient (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Exceptions to confidentiality'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Confidentiality also may be threatened by laws that grant parents explicit access to the minors' complete medical records, financial obligations, and ancillary staff. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Potential threats to confidentiality'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/1\">",
"      Cutler EM, Bateman MD, Wollan PC, Simmons PS. Parental knowledge and attitudes of Minnesota laws concerning adolescent medical care. Pediatrics 1999; 103:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/2\">",
"      Weddle M, Kokotailo P. Adolescent substance abuse. Confidentiality and consent. Pediatr Clin North Am 2002; 49:301.",
"     </a>",
"    </li>",
"    <li>",
"     Policy Compendium on Confidential Health Services for Adolescents, 2nd ed, Morreale M, Stinnett AJ, Dowling EC (Eds), Center for Adolescent Health and the Law, Chapel Hill, NC, 2005. Available at: www.cahl.org/PDFs/PolicyCompendium/PolicyCompendium.pdf (Accessed on October 31, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/4\">",
"      Larcher V. Consent, competence, and confidentiality. BMJ 2005; 330:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/5\">",
"      Confidential health services for adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1993; 269:1420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/6\">",
"      ACOG educational bulletin. Confidentiality in adolescent health care. Number 249, August 1998. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1998; 63:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/7\">",
"      Ford CA, Thomsen SL, Compton B. Adolescents' interpretations of conditional confidentiality assurances. J Adolesc Health 2001; 29:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/8\">",
"      Thrall JS, McCloskey L, Ettner SL, et al. Confidentiality and adolescents' use of providers for health information and for pelvic examinations. Arch Pediatr Adolesc Med 2000; 154:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/9\">",
"      Jones RK, Purcell A, Singh S, Finer LB. Adolescents' reports of parental knowledge of adolescents' use of sexual health services and their reactions to mandated parental notification for prescription contraception. JAMA 2005; 293:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/10\">",
"      Ford CA, Millstein SG, Halpern-Felsher BL, Irwin CE Jr. Influence of physician confidentiality assurances on adolescents' willingness to disclose information and seek future health care. A randomized controlled trial. JAMA 1997; 278:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/11\">",
"      Lehrer JA, Pantell R, Tebb K, Shafer MA. Forgone health care among U.S. adolescents: associations between risk characteristics and confidentiality concern. J Adolesc Health 2007; 40:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/12\">",
"      Ford CA, Millstein SG. Delivery of confidentiality assurances to adolescents by primary care physicians. Arch Pediatr Adolesc Med 1997; 151:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/13\">",
"      Lovett J, Wald MS. Physician attitudes toward confidential care for adolescents. J Pediatr 1985; 106:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/14\">",
"      Greydanus DE, Patel DR. Consent and confidentiality in adolescent health care. Pediatr Ann 1991; 20:80.",
"     </a>",
"    </li>",
"    <li>",
"     American Medical Association. Report of the Council of Scientific Affairs. Confidential Care for Minors. Available at: www.ama-assn.org (Accessed on February 06, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/16\">",
"      American Academy of Family Physicians, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Adolescent Medicine. Protecting adolescents: Ensuring access to care and reporting sexual activity and abuse. J Adolesc Health 2004; 35:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/17\">",
"      Committee on Bioethics. Policy statement--Physician refusal to provide information or treatment on the basis of claims of conscience. Pediatrics 2009; 124:1689.",
"     </a>",
"    </li>",
"    <li>",
"     Boonstra H, Nash E. Minors and the right to consent to health care. The Alan Guttmacher Institute, New York 2000. Available at: www.guttmacher.org/pubs/tgr/03/4/gr030404.html (Accessed on October 31, 2012).",
"    </li>",
"    <li>",
"     Hofmann AD. Legal issues in adolescent medicine. In: Adolescent Medicine, Hofmann AD, Greydanus DE (Eds), Appleton and Lange, Stamford, CT 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/20\">",
"      The adolescent's right to confidential care when considering abortion. American Academy of Pediatrics. Committee on Adolescence. Pediatrics 1996; 97:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/21\">",
"      Wartenberg D, Thompson WD. Privacy versus public health: the impact of current confidentiality rules. Am J Public Health 2010; 100:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/22\">",
"      Ford C, English A, Sigman G. Confidential Health Care for Adolescents: position paper for the society for adolescent medicine. J Adolesc Health 2004; 35:160.",
"     </a>",
"    </li>",
"    <li>",
"     Glosser A, Gardiner K, Fishman M. Statutory rape: a guide to state laws and reporting requirements. The Lewin Group 2004. Available at: www.lewin.com/publications/publication/75/ (Accessed on October 31, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/24\">",
"      Madison AB, Feldman-Winter L, Finkel M, McAbee GN. Commentary: consensual adolescent sexual activity with adult partners--conflict between confidentiality and physician reporting requirements under child abuse laws. Pediatrics 2001; 107:E16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/25\">",
"      Shain BN, American Academy of Pediatrics Committee on Adolescence. Suicide and suicide attempts in adolescents. Pediatrics 2007; 120:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/26\">",
"      Press BR, Khan SA. Management of the suicidal child or adolescent in the emergency department. Curr Opin Pediatr 1997; 9:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/27\">",
"      Kachigian C, Felthous AR. Court responses to Tarasoff statutes. J Am Acad Psychiatry Law 2004; 32:263.",
"     </a>",
"    </li>",
"    <li>",
"     Gostin LO. Surveillance and public health research: privacy and the \"right to know\" In: Public Health Law and Ethics, 2002. Available at: www.publichealthlaw.net/Reader/ch10/ch10.htm (Accessed on October 31, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/29\">",
"      Ethical principles of psychologists and code of conduct. Am Psychol 2002; 57:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/30\">",
"      Rae WA, Sullivan JR, Razo NP, et al. Adolescent health risk behavior: when do pediatric psychologists break confidentiality? J Pediatr Psychol 2002; 27:541.",
"     </a>",
"    </li>",
"    <li>",
"     Hofmann AD. Consent and confidentiality. In: Adolescent Medicine, 3rd ed, Greydanus D, Hofmann AD (Eds), Appleton and Lange, Stamford, CT 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/32\">",
"      English A, Ford CA. The HIPAA privacy rule and adolescents: legal questions and clinical challenges. Perspect Sex Reprod Health 2004; 36:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/33\">",
"      Roscam Abbing HD. Medical confidentiality and electronic patient files. Med Law 2000; 19:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/34\">",
"      Spooner SA, Council on Clinical Information Technology, American Academy of Pediatrics. Special requirements of electronic health record systems in pediatrics. Pediatrics 2007; 119:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/35\">",
"      Committee on Adolescence, Council on Clinical and Information Technology, Blythe MJ, Del Beccaro MA. Standards for health information technology to ensure adolescent privacy. Pediatrics 2012; 130:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/36\">",
"      Litt IF. Adolescent patient confidentiality: whom are we kidding? J Adolesc Health 2001; 29:79.",
"     </a>",
"    </li>",
"    <li>",
"     English A. Legal Aspects of Care. In: Textbook of Adolescent Medicine, 1st ed, McAnarney ER, Kreipe RE, Orr DP, Comerci GD (Eds), WB Saunders, Philadelphia 1992.",
"    </li>",
"    <li>",
"     Morrissey JM, Hofmann AD, Thrope JC. nt and Confidentiality in the Health Care of Children and Adolescents: A Legal Guide, The Free Press, New York 1986.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/39\">",
"      English A. Treating adolescents. Legal and ethical considerations. Med Clin North Am 1990; 74:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/40\">",
"      Rainey DY, Brandon DP, Krowchuk DP. Confidential billing accounts for adolescents in private practice. J Adolesc Health 2000; 26:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/41\">",
"      Fisher M, Marks A, Trieller K, Brody R. Are adolescents able and willing to pay the fee for confidential health care? J Pediatr 1985; 107:480.",
"     </a>",
"    </li>",
"    <li>",
"     Guttmacher Institute. State policies in brief. Minors' access to contraceptive services. Available at: www.guttmacher.org/sections/adolescents.php (Accessed on October 31, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/43\">",
"      Akinbami LJ, Gandhi H, Cheng TL. Availability of adolescent health services and confidentiality in primary care practices. Pediatrics 2003; 111:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/44\">",
"      Klerman LV. How legislation and health systems can promote adolescent health. Adolesc Med 1999; 10:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/45\">",
"      Conard LA, Fortenberry JD, Blythe MJ, Orr DP. Pharmacists' attitudes toward and practices with adolescents. Arch Pediatr Adolesc Med 2003; 157:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/46\">",
"      American Pharmacists Association. Report of the 2004 APhA House of Delegates. J Am Pharm Assoc 2004; 44:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10281/abstract/47\">",
"      Alford S, Davis L, Brown L. Pharmacists' attitudes and awareness of emergency contraception for adolescents. Transitions 2001; 12:1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 106 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-189.41.172.26-F4C67BF9F9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10281=[""].join("\n");
var outline_f10_2_10281=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONFIDENTIALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Conditional versus unconditional",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12770562\">",
"      Public health perspective",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EXCEPTIONS TO CONFIDENTIALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Child abuse/neglect",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Consensual sexual activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Suicidal ideation or attempt",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Homicidal ideation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Violent injuries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Mental health care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Parental notification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      POTENTIAL THREATS TO CONFIDENTIALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Medical records",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - HIPAA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - FERPA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Electronic records",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Payment for services",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Who is liable?",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Method of payment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Ancillary staff",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Pharmacists",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/106\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/106|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/0/30720\" title=\"figure 1\">",
"      Confidentiality agreement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/106|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/30/43499\" title=\"table 1\">",
"      Description confidential office visit",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18408?source=related_link\">",
"      Child neglect and emotional abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5512?source=related_link\">",
"      Consent in adolescent health care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/11/38071?source=related_link\">",
"      Evaluation and management of suicidal behavior in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=related_link\">",
"      Evaluation of sexual abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/15/11510?source=related_link\">",
"      Management and sequelae of sexual abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=related_link\">",
"      Physical abuse in children: Diagnostic evaluation and management",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_2_10282="Body piercing in adolescents and young adults";
var content_f10_2_10282=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Body piercing in adolescents and young adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/2/10282/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/2/10282/contributors\">",
"     R Michelle Schmidt, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/2/10282/contributors\">",
"     Myrna L Armstrong, EdD, RN, FAAN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/2/10282/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/2/10282/contributors\">",
"     Amy B Middleman, MD, MPH, MS Ed",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/2/10282/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/2/10282/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/2/10282/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many healthcare professionals associate body art with criminal activity or psychiatric disturbance, based in part on some early descriptive studies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]; some are still trying to make that case [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Individuals often associate tattoos and body piercings with gang members, prisoners, military personnel, or rebellious teenagers [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In reality, however, a variety of people, including professionals, clergy, or other \"respected members of society\" acquire body art for an assortment of reasons. Unfortunately, a healthcare professional's negative attitude about body art may interfere with the optimal treatment of patients with these types of ornamentation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The history and health hazards associated with body piercing will be reviewed here. Tattooing is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/9/35993?source=see_link\">",
"     \"Tattooing in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Body piercing has a long history, with rumored reports of Roman centurions wearing nipple rings in their breast plates to hold their capes in place and as a sign of loyalty to their Emperor [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The Mayans are believed to have pierced their tongues as part of spiritual rituals [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Queen Victoria's husband, Prince Albert of Saxe-Coburg and Gotha, also is rumored to have had his penis pierced, although the veracity of this assertion is unproven [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/6,10,11\">",
"     6,10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Information regarding the prevalence of tattooing and body piercing among adolescents and young adults continues to be published, and the numbers show progressively increasing amounts of body art, which has become mainstream among individuals aged 16 to 25 years [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/12-17\">",
"     12-17",
"    </a>",
"    ]. Data from surveys of high school and college students (13 to 25 years of age) indicate a prevalence of 25 to 35 percent for body piercing (excluding traditional earlobe piercing in males and females) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/13,14,18-20\">",
"     13,14,18-20",
"    </a>",
"    ]. Nearly one-half of 225 adolescents surveyed at an urban, hospital-based adolescent clinic reported piercings (earlobe piercings were excluded in females but not males; 58 percent of respondents were African American, and 30 percent were Caucasian) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/15\">",
"     15",
"    </a>",
"    ]. In a 2007 Pew Research Center report examining how young people view their lives, 30 percent of 18- to 25-year-olds and 22 percent of 26- to 40-year-olds have at least one piercing other than earlobe sites [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although body piercing has been associated with risk-taking behaviors, the population sampled appears to affect the behaviors associated with body art [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/4\">",
"     4",
"    </a>",
"    ]. In a small survey (484 adolescents), tattooing and body piercing were associated with disordered eating behaviors, gateway drug use, hard drug use, sexual activity, and suicide [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/4\">",
"     4",
"    </a>",
"    ]. In another study, college students with body piercings reported substantively and significantly greater frequency of premarital sexual activity than nonpierced college students [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Individuals with piercings may readily admit that they are risk-takers, but studies of college students have found an inconsistent frequency of high-risk behaviors among pierced youth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/12,17,18,22-24\">",
"     12,17,18,22-24",
"    </a>",
"    ]. One study found that college students with four or more tattoos, seven or more piercings, or piercings located in their nipples or genitals were significantly more likely to report high-risk behaviors than students without these criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/25\">",
"     25",
"    </a>",
"    ]. Students with and without body art share similar demographic characteristics, such as natural parent households, positive family relationships, parents with college degrees, daily prayer habits, and moderate to strong religious faith [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/26-28\">",
"     26-28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Motivational factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of motivational factors have been suggested:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The desire to experiment with body art may be a normal developmental drive for some adolescents, a means to redefine themselves and take control of their bodies and their identities.",
"     </li>",
"     <li>",
"      Friends provide major support for the body art. In one study, the magnitude of a friend's influence was about double that of the family's, whether the friends have or do not have body art themselves [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/28\">",
"       28",
"      </a>",
"      ]. Among adolescents, body art may be viewed as normative [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A means of making individuals feel unique [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/13,14,18,27-31\">",
"       13,14,18,27-31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Body piercing is sometimes used as a means of injury during self-mutilation [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PIERCING PROCEDURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Body piercing may be performed by either a commercial or an amateur artist; most body piercing is performed in tattoo studios [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/33\">",
"     33",
"    </a>",
"    ]. Fewer states have regulations for body piercing than for tattooing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/9/35993?source=see_link&amp;anchor=H110578099#H110578099\">",
"     \"Tattooing in adolescents and adults\", section on 'The tattooing process'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Before piercing is performed, the client selects both the body part to be pierced and the jewelry for the piercing site. Jewelry is typically made of 300 grade surgical steel, niobium, titanium, or gold, to prevent contact dermatitis. The skin is cleansed with an alcohol-and-iodine solution before it is pierced. No topical or local anesthesia generally is applied. For earlobes, the equipment used depends on the type of piercing establishment. Studio piercers use regular straight, sterilized needles, usually a 12- to 16-gauge hollow-bore needle. After the hole has been established, jewelry is guided through the hollow-bore needle using a string or wire.",
"   </p>",
"   <p>",
"    The piercer should give the client after-care instructions for cleaning and maintaining the piercing site; these include cleansing of the site twice daily with an antimicrobial soap and reminding the client to avoid contact with the site except for cleaning [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/9,34\">",
"     9,34",
"    </a>",
"    ]. Complications can occur any time after the piercing when serosanguineous fluid and blood are released with these puncture wounds. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Health risks'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Earlobe or high-rim piercings also are frequently performed at commercial establishments and kiosks in shopping malls. Many of these establishments use a \"cartridge-loaded\" gun that contains the earring stud, and some continue to use \"spring-loaded\" guns that can produce trauma around the opening. These establishments are popular because they do not charge for the piercing procedure, although the customer may be strongly encouraged to buy the \"after-care solution\" (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Localized infection'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Amateur piercing is performed by oneself or friends using crude instruments in a variety of environments, which can lead to infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/9\">",
"     9",
"    </a>",
"    ]. The navel is the most common self-pierced site. Amateur piercing may lack the proper technique and depth, leading to rejection of the jewelry from the skin. The jewelry may be pushed out of the skin because of the formation of scar tissue.",
"   </p>",
"   <p>",
"    With the popularity of body piercing in the US since the mid-1990s, creativity continues with new types of body modification activities. Ear gauging is one procedure in which the ear lobe piercing is slowly stretched to accommodate various types of jewelry plugs, tunnels, or other types of hollow jewelry. This type of piercing has historically been widely seen in Africa and South America. The actual piercing is performed as described above, but as the piercing begins to heal, the piercee gradually expands the hole by inserting a larger piece of jewelry every four to six weeks until they achieve the desired expansion. The expansion must be performed gradually or the site of piercing may be damaged, potentially causing skin irritation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    infection. Restoration of ear gauging may require surgical correction [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. A variety of ornament implants include new terms like &ldquo;transdermals&rdquo; (welding piercing jewelry for permanency), &ldquo;genital beading&rdquo; (insertion of beads under the epidermis of the penis), and &ldquo;microdermals&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/37\">",
"     37",
"    </a>",
"    ]. The latter is becoming quite popular, using &ldquo;pocketing&rdquo; (",
"    <a class=\"graphic graphic_figure graphicRef68995 \" href=\"UTD.htm?3/50/3874\">",
"     figure 1",
"    </a>",
"    ) to insert a dermal anchor. This anchor contains holes so tissue can grow through it and secure the special jewelry that is screwed onto it. The effect provides an appearance of jewelry sticking to the skin&rsquo;s surface, often the abdominal area. Surgical excisions sometimes are necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H110585739\">",
"    <span class=\"h1\">",
"     PIERCING SITE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Piercing has been attempted at virtually every external anatomic site. In Western cultures, the earlobe has been the traditional and most accepted site for piercing. However, many other parts of the body, including the tragus or the helix of the ear, the eyebrow, nasal septum, or the ala of the nose, have become popular [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/32\">",
"     32",
"    </a>",
"    ]. The lip can be pierced, as can the tongue and navel. Less traditional piercings may be performed in the uvula, cheek, chest, neck, and knuckles. Insertion of plastic and wood plugs (3-D inserts) or \"pocketing,\" where the ends of the piercing jewelry are embedded into the skin, leaving the middle of the shank exposed (",
"    <a class=\"graphic graphic_figure graphicRef77828 \" href=\"UTD.htm?37/23/38271\">",
"     figure 2",
"    </a>",
"    ), also may be seen.",
"   </p>",
"   <p>",
"    Genital and nipple piercings (clitoral, clitoral hood, labial, perineal, penile, and scrotal) (",
"    <a class=\"graphic graphic_table graphicRef60273 \" href=\"UTD.htm?9/57/10141\">",
"     table 1",
"    </a>",
"    ) are being obtained more frequently in the young adult population [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/10,12,14,29-32,34,39,40\">",
"     10,12,14,29-32,34,39,40",
"    </a>",
"    ]. Three surveys of individuals with intimate piercings provide information regarding the demographics, motivations, and health concerns of individuals with intimate body piercings [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Health concerns included aspects of pregnancy (including deliveries) and lactation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. According to the LaLeche League (",
"    <a class=\"external\" href=\"file://www.lalecheleague.org/\">",
"     www.LaLecheleague.org",
"    </a>",
"    ), women with healed nipple piercings can breastfeed [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/41\">",
"     41",
"    </a>",
"    ]. Whether the jewelry is left intact during breastfeeding depends on the type of jewelry and the \"latch-on\" of the infant. Any jewelry that poses a risk of aspiration in the infant should be removed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     RISKS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risks associated with body piercing can be divided into purchase risks, possession risks, and health risks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Purchase risks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Purchase risks surround the purchase of a piercing and include expense and pain. Impulsive purchasing of a product, such as when a teen quickly makes a decision in favor of a piercing, can lead to purchase risks. Teens may overpay for body art, endure pain during the procedure, and experience infection because they did not know about the importance of skin care. Adolescents tend to have high purchase risks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Possession risks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Possession risk refers to the risk of a negative response from others when the body piercing is noticed. Although the body piercing may have significant meaning to the adolescent, parents, teachers, and others frequently express displeasure with it. Thus, the piercing has a risk associated with potentiating low self-esteem.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Health risks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Body piercing is associated with health risks, yet the medical literature lacks data on the incidence of these dangers compared with the overall incidence of body art in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/42\">",
"     42",
"    </a>",
"    ]. This lack of data is a result of infrequent reporting of complications to state health departments or in the medical literature, rather than an infrequency of complications.",
"   </p>",
"   <p>",
"    Most health risks are related to infectious complications or localized skin reactions, but the potential of blood-borne diseases is present. As an example, one study of 766 college students with body art reports infection at the piercing site (45 percent), localized skin reaction (39 percent), and two cases of hepatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/14\">",
"     14",
"    </a>",
"    ]. In other surveys of university undergraduates, the incidence of medical complications was 17 to 19 percent among the students with body piercings (including bleeding, tissue trauma, and infection). In a survey of 225 adolescents at an urban hospital-based adolescent clinic, complications of body piercing included infection (74 percent), bleeding (30 percent), allergic reactions (26 percent), bruising (19 percent) and keloids (19 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even earlobe piercings can be a problem. In a retrospective review, embedded earrings accounted for 25 in 100,000 patient visits to a pediatric emergency department between 2000 and 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/43\">",
"     43",
"    </a>",
"    ]. The median age was eight years, 87 percent involved embedded earrings in the ear lobe, and 68 percent involved the posterior portion of the earring. These cases support the American Academy of Pediatrics recommendation that ear piercing be avoided until self-care is achievable [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Localized infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common infectious complications of body piercing, especially navel and ear piercing, is a localized skin infection caused by Staphylococcus aureus and Pseudomonas aeruginosa [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/12,34,45-49\">",
"     12,34,45-49",
"    </a>",
"    ]. The risk of infection is greater in individuals with newly acquired piercings because of diminished skin integrity from procedures, especially those done in warm-weather months [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    High-rim ear piercing is a particular problem because of the lack of vascularity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/46\">",
"     46",
"    </a>",
"    ]. Reports of auricular chondritis, including an outbreak caused by Pseudomonas aeruginosa associated with the use of spring-loaded piercing guns, have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/47,50-52\">",
"     47,50-52",
"    </a>",
"    ]. Another case involving 15 young people requiring surgical treatment and multiple antibiotics from contaminated after-care solution was reported [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32503?source=see_link&amp;anchor=H16#H16\">",
"     \"Other Pseudomonas aeruginosa infections\", section on 'Perichondritis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of infection can be reduced when the individual receiving the piercing understands the procedure, obtains it in a studio that uses sterile procedures, and follows appropriate after-care instructions regarding cleaning and maintenance. We suggest soap and water as an appropriate after-care solution. Some piercing establishments in shopping malls sell benzalkonium chloride as their after-care product of choice. However, benzalkonium chloride does not have adequate microbicidal activity against P. aeruginosa. In addition, it may be contaminated with other microorganisms [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most piercers recommend that the jewelry not be removed, even with a localized infection, to allow the piercing site to maintain an outlet for drainage (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Removal'",
"    </a>",
"    below). To avoid complications, either local or systematic antibiotics are advised promptly, depending upon the severity of cellulitis. The treatment of cellulitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link&amp;anchor=H9#H9\">",
"     \"Cellulitis and erysipelas\", section on 'Cellulitis'",
"    </a>",
"    .) Healing times for body piercing vary according to site, but can take as long as one year for navel piercings and certain genital piercings and up to six weeks with ear piercing and other facial or oral piercings (including tongue piercings) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Systemic infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic infection complicates body piercing less frequently than local infection. Systemic infection is more likely to occur in people who have had amateur body piercings or have not followed the after-care instructions. Cases of tetanus [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/53\">",
"     53",
"    </a>",
"    ], acute poststreptococcal glomerulonephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/54\">",
"     54",
"    </a>",
"    ], streptococcal septicemia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/55\">",
"     55",
"    </a>",
"    ], staphylococcal toxic shock syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/56\">",
"     56",
"    </a>",
"    ], and pseudomonal abscesses [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/57\">",
"     57",
"    </a>",
"    ] have all been documented after body piercing. A case of a mixed-oral-flora cerebellar abscess was reported four weeks after tongue piercing in a patient who developed an early local infection in the tongue and removed the jewelry within six days of the piercing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/58\">",
"     58",
"    </a>",
"    ]. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100653755\">",
"    <span class=\"h4\">",
"     Infective endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since 1991, more than 25 cases of infective endocarditis (IE) associated with body art in adolescents and young adults have been described in the national and international literature; one case resulted in death [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/59-86\">",
"     59-86",
"    </a>",
"    ]. Although the actual number of body art procedures performed in this time frame is unknown, it is on the order of millions per year, suggesting that the risk of IE is exceedingly small. Still, each year, there are new reported cases.",
"   </p>",
"   <p>",
"    Tongue piercing is the most commonly involved site; other sites include the earlobes, navel, and nipple. The cases have occurred in patients with a history of congenital heart disease (CHD), as well as in previously healthy individuals. Various organisms have been involved, including methicillin-susceptible Staphylococcus aureus [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/59,61,63,67,70\">",
"     59,61,63,67,70",
"    </a>",
"    ], methicillin-resistant S. aureus [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/64,66\">",
"     64,66",
"    </a>",
"    ], S. epidermidis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/60\">",
"     60",
"    </a>",
"    ], Streptococcus viridans [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/68\">",
"     68",
"    </a>",
"    ], Haemophilus parainfluenzae [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/65\">",
"     65",
"    </a>",
"    ], H. aphrophilus [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/62\">",
"     62",
"    </a>",
"    ], and Neisseria mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Healthcare providers should consider the possibility of IE in any patient who presents with unusual clinical events (eg, unexplained fever, rigors, weakness, myalgia, arthralgia, lethargy, or malaise) between one week and two months after body piercing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/70,87\">",
"     70,87",
"    </a>",
"    ]. As body art continues to be a mainstream activity, proactive education about the risk of infection is recommended for parents and children. Education about the possibility of IE should be extended into the community to include body artists, since many adolescents may return to the body artist before the healthcare provider if infection occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/42,82,88,89\">",
"     42,82,88,89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American Heart Association does not recommend prophylactic antibiotics for patients with CHD before obtaining body art (tattoos or body piercings) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/90\">",
"     90",
"    </a>",
"    ]. However, it has been suggested by several clinicians who have cared for patients with CHD who developed IE after body art [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/61,87,90-92\">",
"     61,87,90-92",
"    </a>",
"    ], including 61 percent of the physician members of the International Society for Adult Congenital Cardiac Disease (now known as the International Society for Adult Congenital Heart Disease), 57 percent of pediatric cardiologists in 16 medical centers in the United Kingdom, and 28 percent of the Japanese Circulation Society Joint Working Groups for Guidelines for Management of Infective Endocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/91,93,94\">",
"     91,93,94",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis and treatment of infective endocarditis are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27896?source=see_link\">",
"     \"Infective endocarditis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100653819\">",
"    <span class=\"h4\">",
"     Hepatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis B and C can be transmitted during body piercing via reused or inadequately sterilized instruments; however, the actual risk for these infections among individuals with body art is not known [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/95\">",
"     95",
"    </a>",
"    ]. In a systematic review, only 5 of 23 observational studies found an increased risk of hepatitis C among individuals with body piercing (the adjusted odds ratios ranged from 2.0 to 7.3) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/96\">",
"     96",
"    </a>",
"    ]. Within tattooing studies, increased risk for hepatitis C was associated with tattoos applied in prisons or by friends; among studies that identified the venue for tattooing, there was no definitive evidence of increased risk for tattoos applied in studio parlors.",
"   </p>",
"   <p>",
"    Hepatitis B is especially worrisome because it is highly contagious, even with minimal blood exposure, and because state regulations do not require hepatitis B immunization for body piercers [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/31/4602?source=see_link\">",
"     \"Epidemiology, transmission, and prevention of hepatitis B virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=see_link\">",
"     \"Epidemiology and transmission of hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=see_link\">",
"     \"Screening for and diagnosis of chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100653826\">",
"    <span class=\"h4\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many healthcare providers consider body piercing to be a risk factor for HIV infection. In the United States, there have been no clearly established cases of HIV infection caused by body piercing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/34\">",
"     34",
"    </a>",
"    ]. Although HIV may be transmitted through body piercing, the relationship needs to be more clearly defined. Certainly the risk of contracting either hepatitis or HIV can be reduced by using new needles with each piercing and by selecting a studio with an educated artist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/0/31749?source=see_link&amp;anchor=H5#H5\">",
"     \"Epidemiology of pediatric HIV infection\", section on 'Risk factors for HIV acquisition'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Skin reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generalized skin reactions, such as acquired hypersensitivity reactions from the jewelry used in piercing, can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/97\">",
"     97",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link\">",
"     \"Overview of dermatitis\"",
"    </a>",
"    .) Less common skin reactions that may occur with piercing include sarcoidal reactions, scleroderma, keloid formations, and hypertrophic scars [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/98-101\">",
"     98-101",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100653874\">",
"    <span class=\"h4\">",
"     Hypersensitivity reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypersensitivity reactions from body piercing can be avoided by using jewelry that is made of 14K gold, surgical stainless steel, niobium, or titanium [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/10\">",
"     10",
"    </a>",
"    ]. The treatment of allergic contact dermatitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H17#H17\">",
"     \"Overview of dermatitis\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100653987\">",
"    <span class=\"h4\">",
"     Keloid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Keloids are benign fibrous growths present in scar tissue that form because of altered wound healing. In one survey of 32 patients with keloids related to ear piercing, keloids were more likely when earlobes were pierced at or after 11 years of age than before 11 years of age (80 versus 24 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/102\">",
"     102",
"    </a>",
"    ]. The authors suggest that postmenarcheal patients with a family history of keloids be counseled to avoid earlobe piercing to avoid the cosmetic concerns and lowered self-esteem that may result from keloid formation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1847?source=see_link\">",
"     \"Keloids\"",
"    </a>",
"    .) Surgical correction may be necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Oral complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dentists and clinicians should be prepared to manage the oral complications of tongue and lip piercing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/104\">",
"     104",
"    </a>",
"    ]. A high incidence of gingival recession secondary to gingival trauma has been reported with lip piercing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/105-107\">",
"     105-107",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other potential complications include difficulty maintaining adequate oral hygiene, which, combined with mechanical trauma, may lead to localized periodontitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/108-111\">",
"     108-111",
"    </a>",
"    ]; increased salivary flow [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/109\">",
"     109",
"    </a>",
"    ]; chipping, cracking, and fractures of the teeth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/109,112,113\">",
"     109,112,113",
"    </a>",
"    ]; interference with mastication and swallowing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/114\">",
"     114",
"    </a>",
"    ]; and speech impediments [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/104,115\">",
"     104,115",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/46/32489?source=see_link\">",
"     \"Evaluation and management of dental injuries in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32471?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of gingivitis and periodontitis in children and adolescents\", section on 'Periodontitis'",
"    </a>",
"    .) Another case study describes multiple brain abscesses associated with tongue piercing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/116\">",
"     116",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study evaluated the effect of duration of tongue piercing and length of the barbell stem on gingival recession and tooth chipping in 52 adults with tongue piercings [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/117\">",
"     117",
"    </a>",
"    ]. Dental effects were directly related to duration of piercing. No subject with piercing less than two years had gingival recession or tooth chipping; 50 percent of subjects who wore barbells for more than two years had gingival recession on the lingual surface of the lower central incisors; and 47 percent of subjects with piercing for more than four years had tooth chipping of the molars and premolars. The barbell length affects the rate of recession and chipping differently; the rate of recession is increased with long barbells, and the rate of chipping is increased with short barbells.",
"   </p>",
"   <p>",
"    Controversy remains both in the emergency medicine and anesthesia literature about the removal of oral piercings during anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/118-120\">",
"     118-120",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Other complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of other complications can occur, depending upon the site of the piercing:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aspiration of either oral or auricular jewelry is a valid concern, particularly among young children and those who play contact sports [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/121,122\">",
"       121,122",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tongue swelling and edema can lead to airway obstruction [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/123\">",
"       123",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Case reports of prolonged priapism and recurrent condyloma acuminata have been reported with penile piercings [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/124,125\">",
"       124,125",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A case of hyperprolactinemia associated with bilateral nipple rings has been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/126\">",
"       126",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Prolonged bleeding after tongue piercing may lead to hypotensive collapse [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/127\">",
"       127",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Friction from clothes and shearing forces during physical activity can produce abrasions [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/104,128\">",
"       104,128",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Jewelry remaining in the mouth can limit radiographic evaluation by scattering radiation and obscuring visualization of oral injuries [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/104\">",
"       104",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157267063\">",
"    <span class=\"h3\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to body piercing during pregnancy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35816?source=see_link&amp;anchor=H2865321#H2865321\">",
"     \"The skin, hair, nails, and mucous membranes during pregnancy\", section on 'Tattoos and piercing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Forensic evidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adolescents' risk-taking behavior can sometimes predispose those with piercings to involvement in a situation where forensic evidence might need to be gathered [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/129\">",
"     129",
"    </a>",
"    ]. Body piercing tracts or the grooves in jewelry may act as a reservoir for DNA from the victim or the perpetrator. The locations of piercings should always be documented, since piercing hardware can leave patterned injuries or marks (abrasions, bruises) during a violent assault or rape.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     REMOVAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Removal of body piercing simply involves removal of the jewelry, although the hole may remain open. However, the teen may be left with a scar from the jewelry site and may require surgical revision for cosmetic reasons. A consistent proportion of adolescents and young adults (13 to 18 percent) report removing their piercings voluntarily; the reasons they cite for removal include dissatisfaction, infection, and disinterest [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/12,14,27\">",
"     12,14,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many clinicians do not know how to remove jewelry from piercing sites, which can delay or interfere with care for the teenager who arrives in the emergency department as a result of trauma or who is unconscious and needs the jewelry removed because of swelling, infection, or radiologic procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/130\">",
"     130",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The three basic types of body jewelry are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Barbell studs &mdash; Two removable beads on either end of a straight or curved bar; used in the tongue, eyebrow, navel, nipple, clitoris, or glans penis (",
"      <a class=\"graphic graphic_picture graphicRef53202 \" href=\"UTD.htm?5/42/5793\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Labaret studs &mdash; Similar to the barbell except that it has a fixed disc on one end; used in tongue or lower lip with bead end exposed (",
"      <a class=\"graphic graphic_picture graphicRef66322 \" href=\"UTD.htm?13/51/14129\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Captive bead rings &mdash; Used for navel, nipple, and high ear piercings (",
"      <a class=\"graphic graphic_picture graphicRef67161 \" href=\"UTD.htm?19/15/19698\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Piercings that involve the insertion of plastic and wood plugs (3-D inserts) or pocketing require skin incision for removal. Barbells and labarets are removed by holding the bar with forceps and using another pair to unscrew the bead [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/130\">",
"     130",
"    </a>",
"    ]. Captive bead rings are removed by holding the ring on either side of the bead and releasing the tension on the bead. If the tissue around the jewelry is edematous, the best procedure is to compress the edematous tissue and remove the jewelry as described, rather than trying to excise the jewelry. Body piercing jewelry removal kits have been designed by healthcare providers and are commercially available; it provides education and proper tools for removal [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/131,132\">",
"     131,132",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many adolescents and young adults may be reluctant to remove body jewelry because they are afraid the hole will close [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/27\">",
"     27",
"    </a>",
"    ]. They may be more willing to remove the jewelry during elective surgical or diagnostic procedures if alternative means to keep the hole patent are suggested. These include replacing the jewelry with suture material, Teflon posts (available at design studios), or a nonmetallic intravenous (IV) catheter. One technique for temporary removal of piercing jewelry is described below [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/133\">",
"     133",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Disinfect the piercing and pierced area",
"     </li>",
"     <li>",
"      Open the piercing jewelry by removing the bead from the bar or ring",
"     </li>",
"     <li>",
"      Place the tip of a tight-fitting IV catheter (14 or 16 gauge), without the needle, over the threaded tip of the bar",
"     </li>",
"     <li>",
"      Advance the IV catheter caudally, pushing the bar out of the skin tract",
"     </li>",
"     <li>",
"      Remove the jewelry, leaving the IV catheter in the subcutaneous skin as a spacer",
"     </li>",
"     <li>",
"      Reverse the steps of this procedure to replace the jewelry",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is not known how long a piercing will remain open without jewelry if none of the above methods are used to keep it open. Several factors may contribute, including the amount of stretching and movement of the site.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     ROLE OF PRIMARY CARE PROVIDER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are more likely to discuss the issue of body art if the clinician does not speak or act judgmentally. Adolescents in particular are attuned to nonverbal cues. If these are dismissive, a teen may truncate discussions with his or her clinician and instead discuss body art with someone who provides him or her with inaccurate information. Teens often will seek advice from a commercial piercing artist instead of discussing the issue with clinicians [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/10,29,88\">",
"     10,29,88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of the clinician is to provide patients with factual information to permit informed decision-making about body piercing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/134\">",
"     134",
"    </a>",
"    ]. The following guidelines may be used when counseling about body piercing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/10,135\">",
"     10,135",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Remind teens that most reputable studios require individuals to be 18 years old before a piercing can be applied without parental permission. Many studios will not accept a note from the parent and require the parent to accompany his or her child to the studio.",
"     </li>",
"     <li>",
"      Encourage the patients to talk to others who have been pierced.",
"     </li>",
"     <li>",
"      Remind patients they can take time to make decisions about body piercing and urge them not to make the decision under pressure, in haste, or while intoxicated.",
"     </li>",
"     <li>",
"      Patients should consider their choices of body site for piercing carefully. Remind them people may have negative judgments about certain body piercing sites. Encourage placement on body parts where patients have control over who sees the piercing [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/136\">",
"       136",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Encourage patients to examine several studios before selecting one and to watch the artist place a piercing and to avoid commercial establishments in shopping malls. Remind patients of the health risks involved with amateur piercing. Individuals should make sure the artist uses disposable gloves and disposable or adequately sterilized needles before each procedure. Also, the body site for piercing should be thoroughly cleaned with an antimicrobial solution. After-care instructions should be provided.",
"     </li>",
"     <li>",
"      Remind patients that no topical anesthetic is used for piercing.",
"     </li>",
"     <li>",
"      Patients should be aware of risks for infection, including hepatitis B or C, HIV, or local skin infections, even when good technique is used. Allergic reaction to jewelry also may develop. Surgical stainless steel, 14K gold, niobium, and titanium are the best materials for jewelry to reduce the risk of a contact dermatitis.",
"     </li>",
"     <li>",
"      Patients should be aware that most body piercing artists are unlicensed and that most states do not require formal training. Furthermore, the artists are not required to obtain hepatitis B immunization in most states. Piercing studios are loosely regulated, and the depth and quality of standards vary from state to state.",
"     </li>",
"     <li>",
"      Remind patients about the costs involved for application of body piercing.",
"     </li>",
"     <li>",
"      Friends, rather than family, of adolescents seem to influence decisions about body art [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/27\">",
"       27",
"      </a>",
"      ]. Clinicians should provide targeted and repeated education to transmit the message of effective decision-making and evaluation of risks, particularly in adolescents with congenital heart disease [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/82\">",
"       82",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Brochures, health education videos, and additional Web sites are available (",
"      <a class=\"graphic graphic_table graphicRef59132 \" href=\"UTD.htm?33/61/34779\">",
"       table 2",
"      </a>",
"      ). Clinicians should become knowledgeable about the regulations in their cities, counties, and states regarding body art. The National Environmental Health Association (NEHA) has created a professional advisory document for those wishing to develop regulations for the body art industry [",
"      <a class=\"abstract\" href=\"UTD.htm?10/2/10282/abstract/137\">",
"       137",
"      </a>",
"      ]. Several states already have used the NEHA code when implementing newly adopted body art regulations for their states.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/39/9842?source=see_link\">",
"       \"Patient information: Keloids (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/35/2610?source=see_link\">",
"       \"Patient information: Tattoos and body piercings (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H110585620\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Body piercing has become frequent among adolescents and adults. Surveys evaluating the association between body piercing and high-risk behaviors have inconsistent results. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Body piercing may be performed by either a commercial or an amateur artist. The piercing technique and after-care instructions may influence the likelihood of complications. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Piercing procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risks associated with body piercing can be divided into purchase risks (cost, pain), possession risks (negative response from others), and health risks. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Risks'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Health risks include localized infection, systemic infection, skin reactions, and oral complications. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Health risks'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Removal of body piercing simply involves removal of the jewelry, although the hole may remain open. Emergent jewelry removal may be necessary in cases of trauma or loss of consciousness. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Removal'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The role of the primary care clinician is to provide patients with factual information that permits informed decision-making about body piercing. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Role of primary care provider'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/1\">",
"      Raspa RF, Cusack J. Psychiatric implications of tattoos. Am Fam Physician 1990; 41:1481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/2\">",
"      Farrow JA, Schwartz RH, Vanderleeuw J. Tattooing behavior in adolescence. A comparison study. Am J Dis Child 1991; 145:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/3\">",
"      Baker SP, Robertson LS, Spitz WU. Tattoos, alcohol, and violent death. J Forensic Sci 1971; 16:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/4\">",
"      Carroll ST, Riffenburgh RH, Roberts TA, Myhre EB. Tattoos and body piercings as indicators of adolescent risk-taking behaviors. Pediatrics 2002; 109:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/5\">",
"      Roberts TA, Ryan SA. Tattooing and high-risk behavior in adolescents. Pediatrics 2002; 110:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/6\">",
"      Ferguson H. Body piercing. BMJ 1999; 319:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/7\">",
"      Stuppy DJ, Armstrong ML, Casals-Ariet C. Attitudes of health care providers and students towards tattooed people. J Adv Nurs 1998; 27:1165.",
"     </a>",
"    </li>",
"    <li>",
"     Kuchinski A, Pereira P, Armstrong ML. Caring for piercing clients: Attitudes, secondary trauma, and forensic evidence. Mosby's Nursing Consult, August 2006. Available at: www.nursingconsult.com (Accessed on May 20, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/9\">",
"      Armstrong ML. You pierced what? Pediatr Nurs 1996; 22:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/10\">",
"      Armstrong ML, Ekmark E, Brooks B. Body piercing: promoting informed decision making. J Sch Nurs 1995; 11:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/11\">",
"      Sperry K. Tattoos and tattooing. Part I: History and methodology. Am J Forensic Med Pathol 1991; 12:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/12\">",
"      Mayers LB, Judelson DA, Moriarty BW, Rundell KW. Prevalence of body art (body piercing and tattooing) in university undergraduates and incidence of medical complications. Mayo Clin Proc 2002; 77:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/13\">",
"      Forbes GB. College students with tattoos and piercings: motives, family experiences, personality factors, and perception by others. Psychol Rep 2001; 89:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/14\">",
"      Greif J, Hewitt W, Armstrong ML. Tattooing and body piercing. Body art practices among college students. Clin Nurs Res 1999; 8:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/15\">",
"      Gold MA, Schorzman CM, Murray PJ, et al. Body piercing practices and attitudes among urban adolescents. J Adolesc Health 2005; 36:352.e17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/16\">",
"      Laumann AE, Derick AJ. Tattoos and body piercings in the United States: a national data set. J Am Acad Dermatol 2006; 55:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/17\">",
"      Mayers L, Chiffriller S. Sequential survey of body piercing and tattooing prevalence and medical complication incidence among college students. Arch Pediatr Adolesc Med 2007; 161:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/18\">",
"      Drews DR, Allison CK, Probst JR. Behavioral and self-concept differences in tattooed and nontattooed college students. Psychol Rep 2000; 86:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/19\">",
"      Armstrong ML, Owen DC, Roberts AE, Koch JR. College students and tattoos. Influence of image, identity, family, and friends. J Psychosoc Nurs Ment Health Serv 2002; 40:20.",
"     </a>",
"    </li>",
"    <li>",
"     Kohut, A, Parker, K, Keeter, S, et al. How young people view their lives, futures, and politics: A portrait of \"generation next.\" Pew Research Center: For the people and the press, released January 9, 2007. p.21. Full report accessible at file://people-press.org/reports/pdf/300.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/21\">",
"      Koch JR, Roberts AE, Armstrong ML, Owen DC. Requencies and relations of body piercing and sexual experience in college students. Psychol Rep 2007; 101:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/22\">",
"      Nathanson C, Paulhus DL, Williams KM. Personality and misconduct correlates of body modification and other cultural deviance markers. J Res Personality 2006; 40:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/23\">",
"      Tate JC, Shelton BL. Personality correlates of tattooing and body piercing in a college sample: the kids are alright. Personality and Individual Differences 2008; 45:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/24\">",
"      Frederick CM, Bradley KA. A different kind of normal: Psychological and motivational characteristics of young adult tattooers and body piercers. North American Journal of Psychology 2000; 2:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/25\">",
"      Koch JR, Roberts AE, Armstrong ML, Owen DC. Body art, deviance, and American college students. Soc Sci J 2010; 106:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/26\">",
"      Rivardo MG, Keelan CM. Body modifications, sexual activity, and religious practices. Psychol Rep 2010; 106:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/27\">",
"      Armstrong ML, Roberts AE, Owen DC, Koch JR. Contemporary college students and body piercing. J Adolesc Health 2004; 35:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/28\">",
"      Armstrong ML, Roberts AE, Owen DC, Koch JR. Toward building a composite of college student influences with body art. Issues Compr Pediatr Nurs 2004; 27:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/29\">",
"      Caliendo C, Armstrong ML, Roberts AE. Self-reported characteristics of women and men with intimate body piercings. J Adv Nurs 2005; 49:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/30\">",
"      Hogan, L, Rinard, K, Young, C, et, al. A cross-sectional study of men with genital piercings. BJMP 2010; 3:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/31\">",
"      Young C, Armstrong ML, Roberts AE, et al. A triad of evidence for care of women with genital piercings. J Am Acad Nurse Pract 2010; 22:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/32\">",
"      Stirn A. Body piercing: medical consequences and psychological motivations. Lancet 2003; 361:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/33\">",
"      Armstrong ML. Tattooing, body piercing, and permanent cosmetics: a historical and current view of state regulations, with continuing concerns. J Environ Health 2005; 67:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/34\">",
"      Tweeten SS, Rickman LS. Infectious complications of body piercing. Clin Infect Dis 1998; 26:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/35\">",
"      Henderson J, Malata CM. Surgical correction of the expanded earlobe after ear gauging. Aesthetic Plast Surg 2010; 34:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/36\">",
"      Williams AM, Majumder S. Earlobe reconstruction following plug and tunnel piercing. J Plast Reconstr Aesthet Surg 2010; 63:e294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/37\">",
"      Rinard K, Nelius T, Hogan L, et al. Cross-sectional study examining four types of male penile and urethral \"play\". Urology 2010; 76:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/38\">",
"      Kluger N, Monestier S, Blatiere V. Complications related to abdominal microdermal implants during pregnancy. J Plast Reconstr Aesthet Surg 2010; 63:e699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/39\">",
"      Young C, Armstrong ML. What nurses need to know when caring for women with genital piercings. Nurs Womens Health 2008; 12:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/40\">",
"      Armstrong ML, Caliendo C, Roberts AE. Genital piercings: what is known and what people with genital piercings tell us. Urol Nurs 2006; 26:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/41\">",
"      Armstrong ML, Caliendo C, Roberts AE. Pregnancy, lactation and nipple piercings. AWHONN Lifelines 2006; 10:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/42\">",
"      Armstrong ML, Kelly L. Tattooing, body piercing, and branding are on the rise: perspectives for school nurses. J Sch Nurs 2001; 17:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/43\">",
"      Timm N, Iyer S. Embedded earrings in children. Pediatr Emerg Care 2008; 24:31.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Caring for Your School-Age Child: Ages 5 to 12, 3rd Ed. Schor, EL (Ed). Bantam Books 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/45\">",
"      Sperry K. Tattoos and tattooing. Part II: Gross pathology, histopathology, medical complications, and applications. Am J Forensic Med Pathol 1992; 13:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/46\">",
"      Rowshan HH, Keith K, Baur D, Skidmore P. Pseudomonas aeruginosa infection of the auricular cartilage caused by \"high ear piercing\": a case report and review of the literature. J Oral Maxillofac Surg 2008; 66:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/47\">",
"      Keene WE, Markum AC, Samadpour M. Outbreak of Pseudomonas aeruginosa infections caused by commercial piercing of upper ear cartilage. JAMA 2004; 291:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/48\">",
"      Fisher CG, Kacica MA, Bennett NM. Risk factors for cartilage infections of the ear. Am J Prev Med 2005; 29:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/49\">",
"      Long GE, Rickman LS. Infectious complications of tattoos. Clin Infect Dis 1994; 18:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/50\">",
"      Widick MH, Coleman J. Perichondrial abscess resulting from a high ear-piercing--case report. Otolaryngol Head Neck Surg 1992; 107:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/51\">",
"      Hanif J, Frosh A, Marnane C, et al. Lesson of the week: \"High\" ear piercing and the rising incidence of perichondritis of the pinna. BMJ 2001; 322:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/52\">",
"      More DR, Seidel JS, Bryan PA. Ear-piercing techniques as a cause of auricular chondritis. Pediatr Emerg Care 1999; 15:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/53\">",
"      O'Malley CD, Smith N, Braun R, Prevots DR. Tetanus associated with body piercing. Clin Infect Dis 1998; 27:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/54\">",
"      Ahmed-Jushuf IH, Selby PL, Brownjohn AM. Acute post-streptococcal glomerulonephritis following ear piercing. Postgrad Med J 1984; 60:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/55\">",
"      George J, White M. Infection as a consequence of ear piercing. Practitioner 1989; 233:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/56\">",
"      McCarthy VP, Peoples WM. Toxic shock syndrome after ear piercing. Pediatr Infect Dis J 1988; 7:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/57\">",
"      Staley R, Fitzgibbon JJ, Anderson C. Auricular infections caused by high ear piercing in adolescents. Pediatrics 1997; 99:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/58\">",
"      Martinello RA, Cooney EL. Cerebellar brain abscess associated with tongue piercing. Clin Infect Dis 2003; 36:e32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/59\">",
"      Ramage IJ, Wilson N, Thomson RB. Fashion victim: infective endocarditis after nasal piercing. Arch Dis Child 1997; 77:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/60\">",
"      Ochsenfahrt C, Friedl R, Hannekum A, Schumacher BA. Endocarditis after nipple piercing in a patient with a bicuspid aortic valve. Ann Thorac Surg 2001; 71:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/61\">",
"      Weinberg JB, Blackwood RA. Case report of Staphylococcus aureus endocarditis after navel piercing. Pediatr Infect Dis J 2003; 22:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/62\">",
"      Akhondi H, Rahimi AR. Haemophilus aphrophilus endocarditis after tongue piercing. Emerg Infect Dis 2002; 8:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/63\">",
"      Satchithananda DK, Walsh J, Schofield PM. Bacterial endocarditis following repeated tattooing. Heart 2001; 85:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/64\">",
"      Dubose J, Pratt JW. Victim of fashion: Endocarditis after oral piercing. Curr Surg 2004; 61:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/65\">",
"      Friedel JM, Stehlik J, Desai M, Granato JE. Infective endocarditis after oral body piercing. Cardiol Rev 2003; 11:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/66\">",
"      Harding PR, Yerkey MW, Deye G, Storey D. Methicillin resistant Staphylococcus Aureus (MRSA) endocarditis secondary to tongue piercing. J Miss State Med Assoc 2002; 43:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/67\">",
"      Lee SH, Chung MH, Lee JS, et al. A case of Staphylococcus aureus endocarditis after ear piercing in a patient with normal cardiac valve and a questionnaire survey on adverse events of body piercing in college students of Korea. Scand J Infect Dis 2006; 38:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/68\">",
"      Lick SD, Edozie SN, Woodside KJ, Conti VR. Streptococcus viridans endocarditis from tongue piercing. J Emerg Med 2005; 29:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/69\">",
"      Papapanagiotou VA, Foukarakis MG, Fotiadis JN, et al. Native tricuspid valve endocarditis in a young woman. Postgrad Med J 1998; 74:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/70\">",
"      Raja SG, Shad SK, Dreyfus GD. Body piercing: a rare cause of mitral valve endocarditis. J Heart Valve Dis 2004; 13:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/71\">",
"      Tronel H, Chaudemanche H, Pechier N, et al. Endocarditis due to Neisseria mucosa after tongue piercing. Clin Microbiol Infect 2001; 7:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/72\">",
"      Battin M, Fong LV, Monro JL. Gerbode ventricular septal defect following endocarditis. Eur J Cardiothorac Surg 1991; 5:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/73\">",
"      Kovarik A, Setina M, Sulda M, et al. Infective endocarditis of the tricuspid valve caused by Staphylococcus aureus after ear piercing. Scand J Infect Dis 2007; 39:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/74\">",
"      Kloppenburg G, Maessen JG. Streptococcus endocarditis after tongue piercing. J Heart Valve Dis 2007; 16:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/75\">",
"      Batiste C, Bansal RC, Razzouk AJ. Echocardiographic features of an unruptured mycotic aneurysm of the right aortic sinus of Valsalva. J Am Soc Echocardiogr 2004; 17:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/76\">",
"      Barkan D, Abu Fanne R, Elazari-Scheiman A, et al. Navel piercing as a cause for Streptococcus viridans endocarditis: case report, review of the literature and implications for antibiotic prophylaxis. Cardiology 2007; 108:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/77\">",
"      Ferguson AW, Jollands A, Kirkpatrick M, et al. Infective endocarditis presenting with Parinaud's dorsal midbrain syndrome. J Pediatr Ophthalmol Strabismus 2006; 43:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/78\">",
"      Dupont P, Maragnes P, de la Gastine G, et al. [Tricuspid valve endocarditis after umbilical piercing]. Arch Mal Coeur Vaiss 2006; 99:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/79\">",
"      Hoyer A, Silberbach M. Infective endocarditis. Pediatr Rev 2005; 26:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/80\">",
"      Yoshinaga M, Niwa K, Niwa A, et al. Risk factors for in-hospital mortality during infective endocarditis in patients with congenital heart disease. Am J Cardiol 2008; 101:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/81\">",
"      Shebani SO, Miles HF, Simmons P, et al. Awareness of the risk of endocarditis associated with tattooing and body piercing among patients with congenital heart disease and paediatric cardiologists in the United Kingdom. Arch Dis Child 2007; 92:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/82\">",
"      Armstrong ML, DeBoer S, Cetta F. Infective endocarditis after body art: a review of the literature and concerns. J Adolesc Health 2008; 43:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/83\">",
"      Carano N, Agnetti A, Allegri V, et al. Infective endocarditis following body piercing: Presentation of one case due to Gemella morbillorum and review of the literature. Med Sci Monit 2010; 16:CS124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/84\">",
"      Giuliana B, Loredana S, Pasquale S, et al. Complication of nasal piercing by Staphylococcus aureus endocarditis: a case report and a review of literature. Cases J 2010; 3:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/85\">",
"      Toste A, Ferreira L, Oliveira JA, et al. A new risk factor for infective endocarditis. Rev Port Cardiol 2009; 28:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/86\">",
"      Nunes Mdo C, Barbosa FB, Gelape CL, et al. Piercing-related endocarditis presenting with multiple large masses in the right-side chamber of the heart. J Am Soc Echocardiogr 2008; 21:776.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/87\">",
"      Goldrick BA. Bubonic plague and HIV. The delta 32 connection. Am J Nurs 2003; 103:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/88\">",
"      Armstrong ML, Murphy KP. Tattooing: another adolescent risk behavior warranting health education. Appl Nurs Res 1997; 10:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/89\">",
"      Armstrong ML, McConnell C. Tattooing in adolescents: more common than you think--the phenomenon and risks. J Sch Nurs 1994; 10:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/90\">",
"      Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/91\">",
"      Cetta F, Graham LC, Lichtenberg RC, Warnes CA. Piercing and tattooing in patients with congenital heart disease: patient and physician perspectives. J Adolesc Health 1999; 24:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/92\">",
"      Millar BC, Moore JE. Antibiotic prophylaxis, body piercing and infective endocarditis. J Antimicrob Chemother 2004; 53:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/93\">",
"      Delahaye F, Wong J, Mills PG. Infective endocarditis: a comparison of international guidelines. Heart 2007; 93:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/94\">",
"      Niwa K, Nakazawa M, Miyatake K, et al. Survey of prophylaxis and management of infective endocarditis in patients with congenital heart disease: Japanese nationwide survey. Circ J 2003; 67:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/95\">",
"      Hayes MO, Harkness GA. Body piercing as a risk factor for viral hepatitis: an integrative research review. Am J Infect Control 2001; 29:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/96\">",
"      Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis 2012; 54:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/97\">",
"      Dron P, Lafourcade MP, Leprince F, et al. Allergies associated with body piercing and tattoos: a report of the Allergy Vigilance Network. Eur Ann Allergy Clin Immunol 2007; 39:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/98\">",
"      Saleeby ER, Rubin MG, Youshock E, Kleinsmith DM. Embedded foreign bodies presenting as earlobe keloids. J Dermatol Surg Oncol 1984; 10:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/99\">",
"      Buchwald C, Nielsen LH, Rosborg J. Keloids of the external ear. ORL J Otorhinolaryngol Relat Spec 1992; 54:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/100\">",
"      Ng KH, Siar CH, Ganesapillai T. Sarcoid-like foreign body reaction in body piercing: a report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/101\">",
"      Carbone L, Myers L. Scleroderma and body piercing. J Pediatr 2002; 140:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/102\">",
"      Lane JE, Waller JL, Davis LS. Relationship between age of ear piercing and keloid formation. Pediatrics 2005; 115:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/103\">",
"      Music EN, Engel G. Earlobe keloids: a novel and elegant surgical approach. Dermatol Surg 2010; 36:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/104\">",
"      McGeary SP, Studen-Pavlovich D, Ranalli DN. Oral piercing in athletes: implications for general dentists. Gen Dent 2002; 50:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/105\">",
"      Leichter JW, Monteith BD. Prevalence and risk of traumatic gingival recession following elective lip piercing. Dent Traumatol 2006; 22:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/106\">",
"      Kapferer I, Benesch T, Gregoric N, et al. Lip piercing: prevalence of associated gingival recession and contributing factors. A cross-sectional study. J Periodontal Res 2007; 42:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/107\">",
"      Gon&ccedil;alves CS, de Faveri M, Hayacibara MF, et al. Bone loss associated with use of tongue piercing: case report. Dent Today 2009; 28:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/108\">",
"      Maibaum WW, Margherita VA. Tongue piercing: a concern for the dentist. Gen Dent 1997; 45:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/109\">",
"      De Moor RJ, De Witte AM, De Bruyne MA. Tongue piercing and associated oral and dental complications. Endod Dent Traumatol 2000; 16:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/110\">",
"      Kretchmer MC, Moriarty JD. Metal piercing through the tongue and localized loss of attachment: a case report. J Periodontol 2001; 72:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/111\">",
"      Er N, Ozkavaf A, Berbero��lu A, Yamalik N. An unusual cause of gingival recession: oral piercing. J Periodontol 2000; 71:1767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/112\">",
"      Ram D, Peretz B. Tongue piercing and insertion of metal studs: three cases of dental and oral consequences. ASDC J Dent Child 2000; 67:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/113\">",
"      Botchway C, Kuc I. Tongue piercing and associated tooth fracture. J Can Dent Assoc 1998; 64:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/114\">",
"      Price SS, Lewis MW. Body piercing involving oral sites. J Am Dent Assoc 1997; 128:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/115\">",
"      Kopp WK. Piercing. J Am Dent Assoc 1998; 129:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/116\">",
"      Herskovitz MY, Goldsher D, Finkelstein R, et al. Multiple brain abscesses associated with tongue piercing. Arch Neurol 2009; 66:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/117\">",
"      Campbell A, Moore A, Williams E, et al. Tongue piercing: impact of time and barbell stem length on lingual gingival recession and tooth chipping. J Periodontol 2002; 73:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/118\">",
"      DeBoer S, McNeil M, Amundson T. Body piercing and airway management: photo guide to tongue jewelry removal techniques. AANA J 2008; 76:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/119\">",
"      Mercier FJ, Bonnet MP. Tattooing and various piercing: anaesthetic considerations. Curr Opin Anaesthesiol 2009; 22:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/120\">",
"      Kluger N. Body art and pregnancy. Eur J Obstet Gynecol Reprod Biol 2010; 153:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/121\">",
"      Becker PG, Turow J. Earring aspiration and other jewelry hazards. Pediatrics 1986; 78:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/122\">",
"      Schnirring, L. Exploring body art trends: Pierced tongues raise concern. Phys Sportsmed 2003; 31:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/123\">",
"      Mandabach MG, McCann DA, Thompson GE. Body art: another concern for the anesthesiologist. Anesthesiology 1998; 88:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/124\">",
"      Slawik S, Pearce I, Pantelides M. Body piercing: an unusual cause of priapism. BJU Int 1999; 84:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/125\">",
"      Altman JS, Manglani KS. Recurrent condyloma acuminatum due to piercing of the penis. Cutis 1997; 60:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/126\">",
"      Modest GA, Fangman JJ. Nipple piercing and hyperprolactinemia. N Engl J Med 2002; 347:1626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/127\">",
"      Hardee PS, Mallya LR, Hutchison IL. Tongue piercing resulting in hypotensive collapse. Br Dent J 2000; 188:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/128\">",
"      Schnirring, L. Body piercing and sports: An opening for trouble? Phys Sportsmed 1999; 27:27.",
"     </a>",
"    </li>",
"    <li>",
"     Kuchinski, A, Pereira, P, Armstrong, ML. Caring for piercing clients: Attitudes, secondary trauma, and forensic evidence. Mosby's Nursing Consult, August 2006. Available at: www.nursingconsult.com. (Accessed on May 20, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/130\">",
"      Khanna R, Kumar SS, Raju BS, Kumar AV. Body piercing in the accident and emergency department. J Accid Emerg Med 1999; 16:418.",
"     </a>",
"    </li>",
"    <li>",
"     DeBoer, SL. Guide for jewelry removal -- health-care professionals' training (DVD) and removal kit. Available at www.peds-r-us.com. (Accessed on December 31st, 2010.).",
"    </li>",
"    <li>",
"     SerRobCo, Inc. P.O. Box 332, 324 West Pine Avenue, Elm Creek, NE 68836. E-mail: sales@serrobco.com. (Accessed December 6, 2010.)",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/133\">",
"      Muensterer OJ. Temporary removal of navel piercing jewelry for surgery and imaging studies. Pediatrics 2004; 114:e384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/134\">",
"      Vanston DC, Scott JM. Health risks, medical complications and negative social implications associated with adolescent tattoo and body piercing practices. Vulnerable Child and Youth Studies 2008; 3:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/135\">",
"      Armstrong M, McConnell C. Promoting informed decision-making about tattooing for adolescents. J Sch Nurs 1994; 10:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/2/10282/abstract/136\">",
"      Armstrong ML, Roberts AE, Koch JR, et al. Motivation for contemporary tattoo removal: a shift in identity. Arch Dermatol 2008; 144:879.",
"     </a>",
"    </li>",
"    <li>",
"     Body Art: A comprehensive guidebook and model code. Published by NEHA; Denver, CO 1999.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 109 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-210.101.131.231-DF96EE1385-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10282=[""].join("\n");
var outline_f10_2_10282=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H110585620\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Motivational factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PIERCING PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110585739\">",
"      PIERCING SITE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      RISKS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Purchase risks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Possession risks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Health risks",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Localized infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Systemic infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H100653755\">",
"      Infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H100653819\">",
"      Hepatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H100653826\">",
"      HIV infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Skin reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H100653874\">",
"      Hypersensitivity reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H100653987\">",
"      Keloid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Oral complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Other complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H157267063\">",
"      - Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Forensic evidence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      REMOVAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      ROLE OF PRIMARY CARE PROVIDER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110585620\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/109\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/109|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/50/3874\" title=\"figure 1\">",
"      General microdermal jewelry design",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/23/38271\" title=\"figure 2\">",
"      Pocketing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/109|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/42/5793\" title=\"picture 1\">",
"      Barbell stud",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/51/14129\" title=\"picture 2\">",
"      Labaret stud",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/15/19698\" title=\"picture 3\">",
"      Captive bead ring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/109|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/57/10141\" title=\"table 1\">",
"      Genital piercings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/61/34779\" title=\"table 2\">",
"      Body art information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=related_link\">",
"      Epidemiology and transmission of hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/0/31749?source=related_link\">",
"      Epidemiology of pediatric HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/31/4602?source=related_link\">",
"      Epidemiology, transmission, and prevention of hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/46/32489?source=related_link\">",
"      Evaluation and management of dental injuries in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27896?source=related_link\">",
"      Infective endocarditis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1847?source=related_link\">",
"      Keloids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32503?source=related_link\">",
"      Other Pseudomonas aeruginosa infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=related_link\">",
"      Overview of dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32471?source=related_link\">",
"      Overview of gingivitis and periodontitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/39/9842?source=related_link\">",
"      Patient information: Keloids (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/35/2610?source=related_link\">",
"      Patient information: Tattoos and body piercings (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=related_link\">",
"      Screening for and diagnosis of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/9/35993?source=related_link\">",
"      Tattooing in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35816?source=related_link\">",
"      The skin, hair, nails, and mucous membranes during pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_2_10283="Benefits physical activity";
var content_f10_2_10283=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51565&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51565&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Benefits of regular physical activity",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Reduces the risk of dying prematurely",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduces the risk of dying from heart disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduces the risk of stroke",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduces the risk of developing diabetes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduces the risk of developing high blood pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helps reduce blood pressure in people who already have high blood pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduces the risk of developing colon cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduces feelings of depression and anxiety",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helps control weight",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helps build and maintain healthy bones, muscles and joints",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helps older adults become stronger and better able to move about without falling",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Promotes psychological well-being",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10283=[""].join("\n");
var outline_f10_2_10283=null;
var title_f10_2_10284="Radiation preparative regimens";
var content_f10_2_10284=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F60441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F60441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Commonly used radiation-containing preparative regimens for hematopoietic cell transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Combination",
"       </td>",
"       <td class=\"subtitle1\">",
"        Agents",
"       </td>",
"       <td class=\"subtitle1\">",
"        Total dosages",
"       </td>",
"       <td class=\"subtitle1\">",
"        Reference",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        FTBI/Cy",
"       </td>",
"       <td>",
"        FTBI",
"       </td>",
"       <td>",
"        1200 cGy",
"       </td>",
"       <td rowspan=\"2\">",
"        Thomas ED, et al, 1982",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclophosphamide",
"       </td>",
"       <td>",
"        120 mg/kg",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        FTBI/VP16",
"       </td>",
"       <td>",
"        FTBI",
"       </td>",
"       <td>",
"        1320 cGy",
"       </td>",
"       <td rowspan=\"2\">",
"        Blume KG, et al, 1987",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Etoposide",
"       </td>",
"       <td>",
"        60 mg/kg",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        FTBI/VP16/Cy (allogeneic)",
"       </td>",
"       <td>",
"        FTBI",
"       </td>",
"       <td>",
"        1320 cGy",
"       </td>",
"       <td rowspan=\"3\">",
"        Long GD, et al, 1997",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Etoposide",
"       </td>",
"       <td>",
"        60 mg/kg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclophosphamide",
"       </td>",
"       <td>",
"        60 mg/kg",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        FTBI/Mel",
"       </td>",
"       <td>",
"        FTBI",
"       </td>",
"       <td>",
"        1200 cGy",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Melphalan",
"       </td>",
"       <td>",
"        200 mg/kg",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        FTBI/VP16/Cy (autologous)",
"       </td>",
"       <td>",
"        FTBI",
"       </td>",
"       <td>",
"        1200 cGy",
"       </td>",
"       <td>",
"        Weaver CH, et al, 1994",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Etoposide",
"       </td>",
"       <td>",
"        60 mg/kg",
"       </td>",
"       <td>",
"        Horning SJ, et al, 1994",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclophosphamide",
"       </td>",
"       <td>",
"        100 mg/kg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FTBI: fractionated total body irradiation.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10284=[""].join("\n");
var outline_f10_2_10284=null;
var title_f10_2_10285="Latex allergens";
var content_f10_2_10285=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F71927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=14\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F71927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=14\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    <em>",
"     Hevea brasiliensis",
"    </em>",
"    latex allergens",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"       <td class=\"subtitle1\">",
"        MW (kD)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Plant family",
"       </td>",
"       <td class=\"subtitle1\">",
"        Crossreactivity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 1*",
"       </td>",
"       <td>",
"        Rubber elongation factor",
"       </td>",
"       <td>",
"        58/14.6",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        Papain, fig",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 2",
"       </td>",
"       <td>",
"        Beta 1/3 glucanase",
"       </td>",
"       <td>",
"        34-36",
"       </td>",
"       <td>",
"        PR-2",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 3*",
"       </td>",
"       <td>",
"        Prenyltransferase",
"       </td>",
"       <td>",
"        24-27",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 4",
"       </td>",
"       <td>",
"        Microhelix",
"       </td>",
"       <td>",
"        110/115",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 5*",
"       </td>",
"       <td>",
"        Acidic protein",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        Kiwi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 6.01",
"       </td>",
"       <td>",
"        Hevein preprotein (prohevein)",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        PR-3",
"       </td>",
"       <td>",
"        Avocado, banana, chestnut",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 6.02*",
"       </td>",
"       <td>",
"        Hevein protein (mature hevein)",
"       </td>",
"       <td>",
"        4.7",
"       </td>",
"       <td>",
"        PR-3",
"       </td>",
"       <td>",
"        Avocado, banana, chestnut",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 6.03",
"       </td>",
"       <td>",
"        Hevein C-terminal fragment",
"       </td>",
"       <td>",
"        15.3",
"       </td>",
"       <td>",
"        PR-3",
"       </td>",
"       <td>",
"        Avocado, banana, chestnut",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 7",
"       </td>",
"       <td>",
"        Patatin homologue (Hev b 7.01/7.02)",
"       </td>",
"       <td>",
"        43-46",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        Potato (patatin-Sol t 1)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 8",
"       </td>",
"       <td>",
"        <em>",
"         Hevea",
"        </em>",
"        profilin",
"       </td>",
"       <td>",
"        14-14.2",
"       </td>",
"       <td>",
"        Profilin",
"       </td>",
"       <td>",
"        Pollens, celery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 9",
"       </td>",
"       <td>",
"        <em>",
"         Hevea",
"        </em>",
"        enolase",
"       </td>",
"       <td>",
"        51",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        Molds",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 10",
"       </td>",
"       <td>",
"        Mn superoxide dismutase",
"       </td>",
"       <td>",
"        22-26",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        Molds",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 11",
"       </td>",
"       <td>",
"        Class I chitinase",
"       </td>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        PR-3",
"       </td>",
"       <td>",
"        Banana, avocado",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 12",
"       </td>",
"       <td>",
"        Lipid transfer protein",
"       </td>",
"       <td>",
"        9.4",
"       </td>",
"       <td>",
"        PR-14",
"       </td>",
"       <td>",
"        Peach and other stone fruit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 13",
"       </td>",
"       <td>",
"        Esterase",
"       </td>",
"       <td>",
"        42",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hev b 14",
"       </td>",
"       <td>",
"        Chitinase, glycosidase hydrolase family 18",
"       </td>",
"       <td>",
"        30.2",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * \"Indicator\" proteins useful for assessment of the allergen content of rubber products or as markers of environmental exposure.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10285=[""].join("\n");
var outline_f10_2_10285=null;
var title_f10_2_10286="Contents: Gastroenterology and Hepatology calculators";
var content_f10_2_10286=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?0/37/606\">",
"       Calculators",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Gastroenterology and Hepatology calculators",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Gastroenterology and Hepatology calculators",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Clinical Criteria",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/56/19329\">",
"           Calculator: Blatchford score for gastrointestinal bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/26/28065\">",
"           Calculator: Child Pugh classification for severity of liver disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/28/29121\">",
"           Calculator: Child Pugh classification for severity of liver disease (SI units)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/61/6098\">",
"           Calculator: Crohn's disease activity index (CDAI)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/9/43152\">",
"           Calculator: Glasgow alcoholic hepatitis score",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/33/19985\">",
"           Calculator: Harvey-Bradshaw index of Crohn's disease activity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/29/15825\">",
"           Calculator: Hepatitis discriminant function for corticosteroid therapy in alcoholic hepatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/46/8929\">",
"           Calculator: Mayo score for assessing ulcerative colitis activity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/16/7425\">",
"           Calculator: Ranson criteria for pancreatitis prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/11/27838\">",
"           Calculator: Rockall score for upper gastrointestinal bleeding",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Medical Equations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/25/37264\">",
"           Calculator: Bedside Index of Severity in Acute Pancreatitis (BISAP) score",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/23/21874\">",
"           Calculator: MELD score for end-stage liver disease (not appropriate for patients under the age of 12)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/2/18466\">",
"           Calculator: MELD score for end-stage liver disease (not appropriate for patients under the age of 12) (SI units)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/39/14962\">",
"           Calculator: MELDNa score for end-stage liver disease (not appropriate for patients under the age of 12)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/38/11874\">",
"           Calculator: MELDNa score for end-stage liver disease (not appropriate for patients under the age of 12) (SI units)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/26/32162\">",
"           Calculator: Mortality risk in post-operative patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/40/9860\">",
"           Calculator: PELD score for end-stage liver disease (patients less than 12 years old)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/42/9890\">",
"           Calculator: Stool osmolal gap",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-823C0CB2B2-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f10_2_10286=[""].join("\n");
var outline_f10_2_10286=null;
var title_f10_2_10287="Reynders Noppen Tygon stent";
var content_f10_2_10287=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F64690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F64690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Reynders-Noppen tygon tracheal stent with screw threads",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 209px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    More rigid than the silicone stents, placement requires a specific introducer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_2_10287=[""].join("\n");
var outline_f10_2_10287=null;
